Hill-Rom (HRC) 10-Q 25 Jan 19 2019 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Dec. 31, 2018	Jan. 22, 2019
Document And Entity Information Abstract
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Dec. 31, 2018
Entity Registrant Name	Hill-Rom Holdings, Inc.
Entity Central Index Key	47,518
Current Fiscal Year End Date	--09-30
Document Fiscal Year Focus	2,019
Document Fiscal Period Focus	Q1
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		66,663,683
Trading Symbol	HRC
Entity Emerging Growth Company	false
Entity Small Business	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Millions	3 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Product sales and service revenue	$ 611.6	$ 575.2
Net Revenue
Product sales and service	683.5	669.7
Rental revenue	71.9	94.5
Cost of Revenue
Rental expenses	37.2	46
Cost of Revenue	353.5	350.1
Total cost of net revenue	316.3	304.1
Gross Profit	330	319.6
Research and development expenses	33.2	32.3
Selling and administrative expenses	218	221.7
Special charges	8	13.5
Operating Profit	70.8	52.1
Interest expense	(21.3)	(23.1)
Investment income and other, net	0.1	1.8
Income Before Income Taxes	49.6	30.8
Income tax expense (benefit)	7.4	(57.5)
Net Income	42.2	88.3
Net Income	$ 42.2	$ 88.3
Net Income Attributable to Common Shareholders per Common Share - Basic (usd per share)		$ 1.34
Net Income Attributable to Common Shareholders per Common Share - Diluted (usd per share)		1.31
Dividends per Common Share (usd per share)	$ 0.2	$ 0.18
Average Common Shares Outstanding - Basic (thousands) (Note 10) (in shares)	67,053	65,906
Average Common Shares Outstanding - Diluted (thousands) (Note 10) (in shares)	67,725	67,432

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Statement of Comprehensive Income [Abstract]
Net Income	$ 42.2	$ 88.3
Other Comprehensive (Loss) Income, net of tax (Note 7):
Derivative instruments and hedges	(3.7)	3.4
Foreign currency translation adjustment	(13.6)	6.1
Change in pension and postretirement defined benefit plans	0.4	0.8
Total Other Comprehensive Income (Loss), net of tax	(16.9)	10.3
Total Comprehensive Income	$ 25.3	$ 98.6

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Dec. 31, 2018	Sep. 30, 2018
Current Assets
Cash and cash equivalents	$ 184.2	$ 183
Trade accounts receivable, net of allowances (Note 3)	537.9	580.7
Inventories, net of reserves (Note 3)	299.9	291.7
Other current assets	114.3	100.2
Total current assets	1,136.3	1,155.6
Property, plant and equipment, net (Note 3)	316.2	328.3
Goodwill (Note 5)	1,731.9	1,738.3
Other intangible assets and software, net (Note 3)	1,037.3	1,027.7
Deferred income taxes (Notes 1 and 10)	34.9	35
Other assets	93.7	75.1
Total Assets	4,350.3	4,360
Current Liabilities
Trade accounts payable	168.8	177.3
Short-term borrowings (Note 6)	188.4	182.5
Accrued compensation	84.2	132.5
Accrued product warranties (Note 13)	24.9	20.5
Accrued rebates	45.9	42.5
Deferred Revenue	84.4	40
Other current liabilities	71.6	67.1
Total current liabilities	668.2	662.4
Long-term debt (Note 6)	1,816.5	1,790.4
Accrued pension and postretirement benefits (Note 7)	68.9	69.3
Deferred income taxes (Notes 1 and 10)	170.1	181.3
Other long-term liabilities	75.1	40.4
Total Liabilities	2,798.8	2,743.8
Commitments and Contingencies (Note 14)
SHAREHOLDERS' EQUITY
Common stock (Notes 3 and 12)	4.4
Additional paid-in capital	606.9
Retained earnings	1,899.9
Accumulated other comprehensive loss (Note 8)	(135.3)
Treasury stock, at cost (Note 3)	(824.4)
Total Shareholders’ Equity	1,551.5	1,616.2
Total Shareholders' Equity	1,551.5	1,616.2
Total Liabilities and Shareholders’ Equity	$ 4,350.3	$ 4,360

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Statement of Cash Flows [Abstract]
Payments Related to Tax Withholding for Share-based Compensation	$ (3.5)	$ (3.5)
Treasury Stock, Value, Acquired, Cost Method	(75)
Operating Activities
Net income	42.2	88.3
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and Amortization of PP&E and Software	18.1	22.9
Acquisition-related intangible asset amortization	25.7	26.7
Amortization of Debt Issuance Costs and Discounts	1.6	1.8
Benefit for deferred income taxes	(4.4)	(86.4)
(Gain) loss on disposal of property, equipment leased to others, intangible assets, and impairments	0.7	(0.6)
Gain on disposition of business	0	(1)
Stock compensation	5.5	6.3
Change in working capital excluding cash, current debt, acquisitions and dispositions:
Trade accounts receivable	69.4	69.6
Inventories	(6.9)	(13.1)
Other current assets	9	(5.2)
Trade accounts payable	(5.9)	(17.7)
Accrued expenses and other liabilities	(42.8)	(24)
Other, net	3.8	25.5
Net cash provided by operating activities	116	93.1
Investing Activities
Purchases of property, plant, equipment and software	(15)	(27.3)
Proceeds on sale of property and equipment leased to others	0.1	1.6
Payments to Acquire Intangible Assets	17.1	0
Payments to Acquire Other Investments	(26.6)	0
Proceeds on sale of business	0	1
Other, net	0.1	(0.4)
Net cash used in investing activities	(58.5)	(25.1)
Financing Activities
Payments of long-term debt	0	(27.4)
Borrowings on Revolving Credit Facility	50	30
Payments on Revolving Credit Facility	(25)	(80)
Borrowings on Securitization Program	0.4	30.9
Payments on Securitization Program	(0.4)	(16.6)
Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement	7.8	0
Payments on Note Securitization Facility	1.9	0
Payments of cash dividends	(13.3)	(11.9)
Proceeds on exercise of stock options	4.6	8
Stock repurchases for stock award withholding obligations		0
Proceeds from (Payments for) Other Financing Activities	1.7	2.4
Net cash used in financing activities	(54.6)	(68.1)
Effect of exchange rate changes on cash and cash equivalents	(1.7)	2
Net Cash Flows	1.2	1.9
Cash and Cash Equivalents:
At beginning of period	183	231.8
At end of period	$ 184.2	$ 233.7

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Shareholders' Equity (unaudited) Statement - USD ($) $ in Millions	Total	Noncontrolling Interest [Member]	Treasury Stock [Member]	Common Stock [Member]	Parent [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Additional Paid-in Capital [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$ 1,365.6	$ 7.4	$ (796.8)	$ 4.4	$ 1,358.2	$ 1,676.2	$ (110)	$ 584.4
Common Stock, Shares, Outstanding			22,643,840	65,813,794
Other Comprehensive Income (Loss), Net of Tax	10.3						10.3
Net Income	88.3				88.3
Net Income (Loss) Attributable to Parent	88.3
Stock Issued During Period, Value, Employee Stock Purchase Plan	1.5		$ 0.6		1.5			0.9
Stock Issued During Period, Shares, Employee Stock Purchase Plans			(17,680)	17,680
Adjustments to Additional Paid in Capital, Share-based Compensation, Restricted Stock Unit or Restricted Stock Award, Requisite Service Period Recognition								(3.9)
Stock Issued During Period, Value, Restricted Stock Award, Gross			$ 3.9
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period			(110,867)	110,867
Stock Issued During Period, Value, Stock Options Exercised	8.1		$ 8.5		8.1			(0.4)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period			(240,856)	240,856
Share-based Compensation on Equity-Classified Awards	6.1				6.1			6.1
Dividends	(11.9)				(11.9)	(12)		(0.1)
Shares Paid for Tax Withholding for Share Based Compensation			43,374	(43,374)
Payments Related to Tax Withholding for Share-based Compensation	(3.5)				3.5
Other Comprehensive Income (Loss), Tax							2.3
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | VIE Activity [Member]	(0.4)	(0.4)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	1,464.1	$ 7	$ (787.3)	$ 4.4	1,457.1	1,752.5	(99.7)	587.2
Common Stock, Shares, Outstanding			22,317,811	66,139,823
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$ 1,616.2		$ (754.3)	$ 4.4		1,876.2	(113)	602.9
Common Stock, Shares, Outstanding	67,256,112		21,201,522	67,256,112
Cumulative Effect on Retained Earnings, Tax | Accounting Standards Update 2014-09 [Member]	$ 4.8
Cumulative Effect on Retained Earnings, Tax | Accounting Standards Update 2016-16 [Member]	0.2
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	(5.4)					5.4	(5.4)
Cumulative Effect on Retained Earnings, Net of Tax | Accounting Standards Update 2014-09 [Member]	(4.9)					(4.9)
Cumulative Effect on Retained Earnings, Net of Tax | Accounting Standards Update 2016-16 [Member]	(5.6)
Other Comprehensive Income (Loss), Net of Tax	(16.9)						(16.9)
Net Income	42.2
Net Income (Loss) Attributable to Parent	42.2
Stock Issued During Period, Value, Employee Stock Purchase Plan	1.9		$ 0.8					1.1
Stock Issued During Period, Shares, Employee Stock Purchase Plans			(21,445)	21,445
Adjustments to Additional Paid in Capital, Share-based Compensation, Restricted Stock Unit or Restricted Stock Award, Requisite Service Period Recognition								(4)
Stock Issued During Period, Value, Restricted Stock Award, Gross			$ 4
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period			(112,464)	112,464
Stock Issued During Period, Value, Stock Options Exercised	4.6		$ 3.6					1
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period			(97,575)	97,575
Share-based Compensation on Equity-Classified Awards	5.8							5.8
Dividends	(13.3)					(13.4)		(0.1)
Shares Paid for Tax Withholding for Share Based Compensation			37,445	(37,445)
Payments Related to Tax Withholding for Share-based Compensation	$ (3.5)
Treasury Stock, Shares, Acquired	800,000		792,264	(792,264)
Payments for Repurchase of Common Stock	$ (75)				$ (75)
Other Comprehensive Income (Loss), Tax							(0.1)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$ 1,551.5		$ (824.4)	$ 4.4		$ 1,899.9	$ (135.3)	$ 606.9
Common Stock, Shares, Outstanding	66,657,887		21,799,747	66,657,887

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation and Principles of Consolidation Unless the context otherwise requires, the terms “Hill-Rom,” “the Company,” “we,” “our” and “us” refer to Hill-Rom Holdings, Inc. and its wholly-owned subsidiaries. The unaudited Condensed Consolidated Financial Statements appearing in this Quarterly Report on Form 10-Q should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in Hill-Rom’s latest Annual Report on Form 10-K for the fiscal year ended September 30, 2018 (“ 2018 Form 10-K ”) as filed with the United States (“U.S.”) Securities and Exchange Commission. The September 30, 2018 Condensed Consolidated Balance Sheet was derived from audited Consolidated Financial Statements, but does not include all disclosures required by accounting principles generally accepted in the United States. In the opinion of management, the Condensed Consolidated Financial Statements herein include all adjustments, consisting only of normal recurring adjustments, necessary to state fairly the financial position, results of operations and cash flows for the interim periods presented. Quarterly results are not necessarily indicative of annual results. The Condensed Consolidated Financial Statements include the accounts of Hill-Rom and its wholly-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of certain assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense in the period. Actual results could differ from those estimates. Examples of such estimates include, but are not limited to, income taxes (Notes 1 and 10), accounts receivable reserves (Note 3), accrued warranties (Note 13), goodwill (Note 5), pension expense (Note 7), and commitments and contingencies (Note 15). Revenue Recognition Revenue is recognized as performance obligations are satisfied, either at a point in time or over time, driven by the nature of the obligation that is contracted to be provided to our customers. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is the unit of account in the contract. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Certain of our contracts have multiple performance obligations. For contracts with multiple performance obligations, we allocate the contract’s transaction price to each performance obligation using our best estimate of the standalone selling price of each distinct good or service in the contract. The majority of our capital equipment revenue is recognized at a point in time, primarily based on the transfer of title, except in circumstances where we are also required to install the equipment, for which revenue is recognized upon customer acceptance of the installation. Performance obligations involving the provision of services and revenue from rental usage of our products are recognized over the time period specified in the contractual arrangement with the customer. Shipping and handling activities are considered to be fulfillment activities and are not considered to be a separate performance obligation. Revenue is presented net of several types of variable consideration including rebates, discounts and product returns, which are estimated at the time of sale generally using the expected value method, although the most likely amount method is also used for certain types of variable consideration. These estimates take into consideration historical experience, current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Certain costs associated with obtaining a contract, which primarily comprise sales commissions earned by Company personnel, are capitalized until such time as the related performance obligations are completed and the related revenue is recognized. Contract liabilities arise as a result of cash received from customers at inception of contracts or where the timing of billing for services precedes satisfaction of our performance obligations. Remaining performance obligations represent the portion of the contract price for which work has not been performed, primarily related to installation and service contracts. Taxes assessed by a governmental authority that are directly imposed on a revenue producing transaction between us and our customers, including but not limited to sales taxes, use taxes and value added taxes, are excluded from revenue and cost. See Note 2 for additional information about revenue recognition. Fair Value Measurements Fair value measurements of our financial assets and liabilities are classified and disclosed in one of the following three categories: • Level 1: Financial instruments with unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets and liabilities. • Level 2: Financial instruments with observable inputs other than those included in Level 1 such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3: Financial instruments with unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Unobservable inputs reflect our own assumptions that market participants would use in pricing the asset or liability (including assumptions about risk). Unobservable inputs are developed based on the best information available in the circumstances, which might include our own data. We record cash and cash equivalents, as disclosed on our Condensed Consolidated Balance Sheets, as Level 1 instruments and certain other derivatives and investments as either Level 2 or 3 instruments. Investments measured at Net Asset Value as a practical expedient are not categorized in the fair value hierarchy. Refer to Note 6 for disclosure of our debt instrument and interest rate swap fair values. There have not been significant changes in our classification of assets and liabilities in the fiscal quarter. Income Taxes Hill-Rom and its eligible subsidiaries file a consolidated U.S. income tax return. We file income tax returns in a number of jurisdictions for our foreign operations. We have a variety of deferred tax assets in numerous tax jurisdictions which are computed using an asset and liability approach to reflect the net tax effects of temporary differences between the financial reporting carrying amounts of assets and liabilities and the corresponding income tax amounts. These deferred tax assets are subject to periodic assessment as to recoverability. If it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recognized. In evaluating whether it is more likely than not that we would recover these deferred tax assets, future taxable income, the reversal of existing temporary differences and tax planning strategies are considered. As of December 31, 2018 , we had $79.4 million of valuation allowances on deferred tax assets, on a tax-effected basis, primarily related to certain foreign deferred tax attributes that are not expected to be utilized. The valuation allowance was not materially impacted by the Tax Cuts and Jobs Act (the “Tax Act”) enacted in the United States in December 2017. We believe that our estimates for the valuation allowances recorded against deferred tax assets are appropriate based on current facts and circumstances. We account for uncertain income tax positions using a threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The difference between the tax benefit recognized in the financial statements for an uncertain income tax position and the tax benefit claimed in the tax return is referred to as an unrecognized tax benefit. See Note 10 for further details. Recently Adopted Accounting Standards In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (“ASC 606”), which provides guidance for revenue recognition. The standard’s core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. We adopted the new standard effective October 1, 2018 using the modified retrospective approach. See Note 2 for additional information on the impacts of ASC 606 on our Condensed Consolidated Financial Statements. In January 2016, the FASB issued ASU 2016-01, Financial Instruments (Topic 825-10) - Recognition and Measurement of Financial Assets and Financial Liabilities . This standard requires equity securities to be measured at fair value with changes in fair value recognized through net income and eliminated the cost method for equity securities without readily determinable fair values. In February 2018, the FASB issued ASU 2018-03, Technical Corrections and Improvements to Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities . This standard issued six technical corrections and improvements to clarify guidance in ASU 2016-01, which primarily impacted the accounting for equity investments, financial liabilities under fair value option, and the presentation and disclosure requirements of financial instruments. We adopted ASU 2016-01 and ASU 2018-03 prospectively in the first quarter of fiscal 2019 and the new standards did not have a material impact on our Condensed Consolidated Financial Statements. We applied the practicability election within this standard under which our investments in equities that are not accounted for under the consolidation or equity method of accounting guidance are valued at cost, less impairment, plus or minus observable price changes (in orderly transactions) of an identical or similar investment of the same issuer. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments . The purpose of the standard is to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. The standard addresses specific issues including debt prepayment and extinguishment costs, settlement of zero-coupon debt, contingent consideration payments made after a business combination, proceeds from the settlement of insurance claims and certain life insurance policies, distributions received from equity method investees, beneficial interests in securitization transactions, and the application of the predominance principle in separately identifiable cash flows. We adopted ASU 2016-15 in the first quarter of fiscal 2019 using a retrospective transition method. As a result of the adoption of ASU 2016-15 we elected to continue to use the nature of distribution approach for distributions received from equity method investees. The adoption of ASU 2016-15 did not have a material impact on our Condensed Consolidated Financial Statements. In October 2016, the FASB issued ASU 2016-16, Intra-Entity Transfers of Assets Other Than Inventory (Topic 740) . This standard requires immediate recognition of the income tax consequences of intercompany asset transfers other than inventory. We adopted ASU 2016-16 on October 1, 2018 using the modified retrospective approach with a cumulative effect adjustment directly to retained earnings. The cumulative effect of applying ASU 2016-16 was an adjustment to decrease prepaid taxes by $5.8 million and increase deferred tax assets by $0.2 million with a corresponding decrease to the opening balance of Retained earnings of $5.6 million . In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash . This standard requires that companies include amounts generally described as restricted cash and restricted cash equivalents, along with cash and cash equivalents, when reconciling the beginning-of-period and end-of-period amounts shown on the statement of cash flows. We retrospectively adopted ASU 2016-18 in the first quarter of fiscal 2019. ASU 2016-18 did not have a material impact on our Condensed Consolidated Financial Statements. In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. This standard provides clarification on the definition of a business and provides guidance on whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. We adopted ASU 2017-01 in the first quarter of fiscal 2019. ASU 2017-01 did not have a material impact on our Condensed Consolidated Financial Statements. In February 2017, the FASB issued ASU 2017-07, Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost . This standard requires employers to include only the service cost component of net periodic pension cost in operating expenses, together with other employee compensation costs. The other components of net periodic pension cost, including interest cost, expected return on plan assets, amortization of prior service cost and settlement and curtailment effects, are to be included in non-operating expenses. The amendment allows a practical expedient that permits an employer to use the amounts disclosed in its pension and other postretirement benefit plan note for the prior comparative periods as the estimation basis for applying the retrospective presentation requirements. We adopted ASU 2017-07 in the first quarter of fiscal 2019 and applied the practical expedient upon adoption. ASU 2017-07 did not have a material impact on our Condensed Consolidated Financial Statements. In February 2018, the FASB issued ASU 2018-02, Income Statement – Reporting Comprehensive Income (Topic 220) . The standard allows entities to reclassify tax effects stranded in accumulated other comprehensive income as a result of tax reform to retained earnings. We adopted ASU 2018-02 in the first quarter of fiscal 2019. As a result of the adoption of ASU 2018-02, we reclassified $5.4 million from Accumulated other comprehensive income (loss) to Retained earnings. We applied the individual item approach for releasing income tax effects from Accumulated other comprehensive income (loss). Recently Issued Accounting Standards In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) . From the lessee’s perspective, the new standard establishes a right-of-use (“ROU”) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement for a lessee. From the lessor’s perspective, the new standard requires a lessor to classify leases as either sales-type, finance or operating. A lease will be treated as a sale if it transfers all of the risks and rewards, as well as control of the underlying asset, to the lessee. If risks and rewards are conveyed without the transfer of control, the lease is treated as a finance lease. If the lessor does not convey risks and rewards or control, an operating lease results. ASU 2016-02 is effective for our first quarter of fiscal 2020. A modified retrospective transition approach is required for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases, that made 16 technical improvements to ASC 842 focused on the following requirements, among others: the rate implicit in the lease, impairment of the net investment in the lease, lessee reassessment of lease classification, lessor reassessment of lease term and purchase options, variable payments that depend on an index or rate and certain transition adjustments. In July 2018, the FASB also issued ASU 2018-11, Leases (Topic 842): Targeted Improvements . The standard allows companies to use the effective date of the new leases standard as the date of initial application on transition. Companies that elect this transition option will not adjust their comparative period financial information for the effects of ASC 842, not make the new required lease disclosures for periods before the effective date, and carry forward their historical disclosures for comparative periods. Additionally, the standard provides a practical expedient that permits lessors to make an accounting policy election by class of underlying asset to not separate lease and non-lease components if specified criteria are met. In December 2018, the FASB issued ASU 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors . The standard allows companies to use the effective date of the new leases standard as the date of initial application on transition. The standard allows lessors, as an accounting policy election, to not evaluate whether certain sales taxes and other similar taxes are lessor or lessee costs, and instead account for those costs as if they are lessee costs. Additionally, the standard clarifies that lessors should account for costs excluded from the consideration of a contract that are paid by the lessor and reimbursed by the lessee as revenue. Early adoption of these standards is permitted. We are currently in the process of evaluating the impact of the amended guidance on our Condensed Consolidated Financial Statements. In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment . This standard eliminates Step 2 of the goodwill impairment test and requires a goodwill impairment to be measured as the amount by which a reporting unit’s carrying amount exceeds its fair value, not to exceed the carrying amount of its goodwill. ASU 2017-04 is effective for our first quarter of fiscal 2021 and requires a prospective transition method. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement . The purpose of the standard is to improve the overall usefulness of fair value disclosures to financial statement users and reduce unnecessary costs to companies when preparing the disclosures. ASU 2018-13 is effective for our first quarter of fiscal 2021. ASU 2018-13 requires application of the prospective method of transition (for only the most recent interim or annual period presented in the initial fiscal year of adoption) to the new disclosure requirements for (1) changes in unrealized gains and losses included in other comprehensive income and (2) the range and weighted average used to develop significant unobservable inputs for Level 3 fair value measurements. ASU 2018-13 also requires prospective application to any modifications to disclosures made because of the change to the requirements for the narrative description of measurement uncertainty. The effects of all other amendments made by ASU 2018-13 must be applied retrospectively to all periods presented. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. In August 2018, the FASB issued ASU 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Topic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans. The purpose of the standard is to improve the overall usefulness of defined benefit pension and other postretirement plan disclosures to financial statement users and reduce unnecessary costs to companies when preparing the disclosures. ASU 2018-14 is effective for our fourth quarter of fiscal 2021 and requires a retrospective transition method. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract . The update aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). ASU 2018-15 is effective for our first quarter of fiscal 2021 and allows a retrospective or a prospective transition method to all implementation costs incurred after the date of adoption. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. In October 2018, the FASB issued ASU 2018-16, Derivatives and Hedging (Topic 815): Inclusion of the Secured Overnight Financing Rate (SOFR) Overnight Index Swap (OIS) Rate as a Benchmark Interest Rate for Hedge Accounting Purposes. The purpose of the standard is to allow the use of the OIS rate based on the SOFR for hedge accounting purposes, which allows entities to designate changes in the fair values of fixed-rate financial assets or liabilities attributable to the OIS rate as the hedged risk. ASU 2018-16 is effective for our first quarter of fiscal 2020 and requires a prospective application. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. In November 2018, the FASB issued ASU 2018-18, Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606 . The purpose of the standard is to (1) clarify that transactions between participants in a collaborative agreement should be accounted for under Topic 606 and (2) add unit-of-account guidance in Topic 808 to align with Topic 606. ASU 2018-18 is effective for our first quarter of fiscal 2020 and must be applied retrospectively to the first quarter of fiscal 2019, the date of initial application of Topic 606. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. Except as noted above, there have been no significant changes to our assessment of the impact of recently issued accounting standards included in Note 1 of our Consolidated Financial Statements in our 2018 Form 10-K .
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation Unless the context otherwise requires, the terms “Hill-Rom,” “the Company,” “we,” “our” and “us” refer to Hill-Rom Holdings, Inc. and its wholly-owned subsidiaries. The unaudited Condensed Consolidated Financial Statements appearing in this Quarterly Report on Form 10-Q should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in Hill-Rom’s latest Annual Report on Form 10-K for the fiscal year ended September 30, 2018 (“ 2018 Form 10-K ”) as filed with the United States (“U.S.”) Securities and Exchange Commission. The September 30, 2018 Condensed Consolidated Balance Sheet was derived from audited Consolidated Financial Statements, but does not include all disclosures required by accounting principles generally accepted in the United States. In the opinion of management, the Condensed Consolidated Financial Statements herein include all adjustments, consisting only of normal recurring adjustments, necessary to state fairly the financial position, results of operations and cash flows for the interim periods presented. Quarterly results are not necessarily indicative of annual results. The Condensed Consolidated Financial Statements include the accounts of Hill-Rom and its wholly-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of certain assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense in the period. Actual results could differ from those estimates. Examples of such estimates include, but are not limited to, income taxes (Notes 1 and 10), accounts receivable reserves (Note 3), accrued warranties (Note 13), goodwill (Note 5), pension expense (Note 7), and commitments and contingencies (Note 15).
Fair Value Measurements	Fair Value Measurements Fair value measurements of our financial assets and liabilities are classified and disclosed in one of the following three categories: • Level 1: Financial instruments with unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets and liabilities. • Level 2: Financial instruments with observable inputs other than those included in Level 1 such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3: Financial instruments with unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Unobservable inputs reflect our own assumptions that market participants would use in pricing the asset or liability (including assumptions about risk). Unobservable inputs are developed based on the best information available in the circumstances, which might include our own data. We record cash and cash equivalents, as disclosed on our Condensed Consolidated Balance Sheets, as Level 1 instruments and certain other derivatives and investments as either Level 2 or 3 instruments. Investments measured at Net Asset Value as a practical expedient are not categorized in the fair value hierarchy. Refer to Note 6 for disclosure of our debt instrument and interest rate swap fair values.
Income Taxes	Income Taxes Hill-Rom and its eligible subsidiaries file a consolidated U.S. income tax return. We file income tax returns in a number of jurisdictions for our foreign operations. We have a variety of deferred tax assets in numerous tax jurisdictions which are computed using an asset and liability approach to reflect the net tax effects of temporary differences between the financial reporting carrying amounts of assets and liabilities and the corresponding income tax amounts. These deferred tax assets are subject to periodic assessment as to recoverability. If it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recognized. In evaluating whether it is more likely than not that we would recover these deferred tax assets, future taxable income, the reversal of existing temporary differences and tax planning strategies are considered. As of December 31, 2018 , we had $79.4 million of valuation allowances on deferred tax assets, on a tax-effected basis, primarily related to certain foreign deferred tax attributes that are not expected to be utilized. The valuation allowance was not materially impacted by the Tax Cuts and Jobs Act (the “Tax Act”) enacted in the United States in December 2017. We believe that our estimates for the valuation allowances recorded against deferred tax assets are appropriate based on current facts and circumstances. We account for uncertain income tax positions using a threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The difference between the tax benefit recognized in the financial statements for an uncertain income tax position and the tax benefit claimed in the tax return is referred to as an unrecognized tax benefit.
Recently Issued Accounting Standards	Recently Adopted Accounting Standards In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (“ASC 606”), which provides guidance for revenue recognition. The standard’s core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. We adopted the new standard effective October 1, 2018 using the modified retrospective approach. See Note 2 for additional information on the impacts of ASC 606 on our Condensed Consolidated Financial Statements. In January 2016, the FASB issued ASU 2016-01, Financial Instruments (Topic 825-10) - Recognition and Measurement of Financial Assets and Financial Liabilities . This standard requires equity securities to be measured at fair value with changes in fair value recognized through net income and eliminated the cost method for equity securities without readily determinable fair values. In February 2018, the FASB issued ASU 2018-03, Technical Corrections and Improvements to Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities . This standard issued six technical corrections and improvements to clarify guidance in ASU 2016-01, which primarily impacted the accounting for equity investments, financial liabilities under fair value option, and the presentation and disclosure requirements of financial instruments. We adopted ASU 2016-01 and ASU 2018-03 prospectively in the first quarter of fiscal 2019 and the new standards did not have a material impact on our Condensed Consolidated Financial Statements. We applied the practicability election within this standard under which our investments in equities that are not accounted for under the consolidation or equity method of accounting guidance are valued at cost, less impairment, plus or minus observable price changes (in orderly transactions) of an identical or similar investment of the same issuer. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments . The purpose of the standard is to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. The standard addresses specific issues including debt prepayment and extinguishment costs, settlement of zero-coupon debt, contingent consideration payments made after a business combination, proceeds from the settlement of insurance claims and certain life insurance policies, distributions received from equity method investees, beneficial interests in securitization transactions, and the application of the predominance principle in separately identifiable cash flows. We adopted ASU 2016-15 in the first quarter of fiscal 2019 using a retrospective transition method. As a result of the adoption of ASU 2016-15 we elected to continue to use the nature of distribution approach for distributions received from equity method investees. The adoption of ASU 2016-15 did not have a material impact on our Condensed Consolidated Financial Statements. In October 2016, the FASB issued ASU 2016-16, Intra-Entity Transfers of Assets Other Than Inventory (Topic 740) . This standard requires immediate recognition of the income tax consequences of intercompany asset transfers other than inventory. We adopted ASU 2016-16 on October 1, 2018 using the modified retrospective approach with a cumulative effect adjustment directly to retained earnings. The cumulative effect of applying ASU 2016-16 was an adjustment to decrease prepaid taxes by $5.8 million and increase deferred tax assets by $0.2 million with a corresponding decrease to the opening balance of Retained earnings of $5.6 million . In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash . This standard requires that companies include amounts generally described as restricted cash and restricted cash equivalents, along with cash and cash equivalents, when reconciling the beginning-of-period and end-of-period amounts shown on the statement of cash flows. We retrospectively adopted ASU 2016-18 in the first quarter of fiscal 2019. ASU 2016-18 did not have a material impact on our Condensed Consolidated Financial Statements. In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. This standard provides clarification on the definition of a business and provides guidance on whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. We adopted ASU 2017-01 in the first quarter of fiscal 2019. ASU 2017-01 did not have a material impact on our Condensed Consolidated Financial Statements. In February 2017, the FASB issued ASU 2017-07, Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost . This standard requires employers to include only the service cost component of net periodic pension cost in operating expenses, together with other employee compensation costs. The other components of net periodic pension cost, including interest cost, expected return on plan assets, amortization of prior service cost and settlement and curtailment effects, are to be included in non-operating expenses. The amendment allows a practical expedient that permits an employer to use the amounts disclosed in its pension and other postretirement benefit plan note for the prior comparative periods as the estimation basis for applying the retrospective presentation requirements. We adopted ASU 2017-07 in the first quarter of fiscal 2019 and applied the practical expedient upon adoption. ASU 2017-07 did not have a material impact on our Condensed Consolidated Financial Statements. In February 2018, the FASB issued ASU 2018-02, Income Statement – Reporting Comprehensive Income (Topic 220) . The standard allows entities to reclassify tax effects stranded in accumulated other comprehensive income as a result of tax reform to retained earnings. We adopted ASU 2018-02 in the first quarter of fiscal 2019. As a result of the adoption of ASU 2018-02, we reclassified $5.4 million from Accumulated other comprehensive income (loss) to Retained earnings. We applied the individual item approach for releasing income tax effects from Accumulated other comprehensive income (loss). Recently Issued Accounting Standards In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) . From the lessee’s perspective, the new standard establishes a right-of-use (“ROU”) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement for a lessee. From the lessor’s perspective, the new standard requires a lessor to classify leases as either sales-type, finance or operating. A lease will be treated as a sale if it transfers all of the risks and rewards, as well as control of the underlying asset, to the lessee. If risks and rewards are conveyed without the transfer of control, the lease is treated as a finance lease. If the lessor does not convey risks and rewards or control, an operating lease results. ASU 2016-02 is effective for our first quarter of fiscal 2020. A modified retrospective transition approach is required for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases, that made 16 technical improvements to ASC 842 focused on the following requirements, among others: the rate implicit in the lease, impairment of the net investment in the lease, lessee reassessment of lease classification, lessor reassessment of lease term and purchase options, variable payments that depend on an index or rate and certain transition adjustments. In July 2018, the FASB also issued ASU 2018-11, Leases (Topic 842): Targeted Improvements . The standard allows companies to use the effective date of the new leases standard as the date of initial application on transition. Companies that elect this transition option will not adjust their comparative period financial information for the effects of ASC 842, not make the new required lease disclosures for periods before the effective date, and carry forward their historical disclosures for comparative periods. Additionally, the standard provides a practical expedient that permits lessors to make an accounting policy election by class of underlying asset to not separate lease and non-lease components if specified criteria are met. In December 2018, the FASB issued ASU 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors . The standard allows companies to use the effective date of the new leases standard as the date of initial application on transition. The standard allows lessors, as an accounting policy election, to not evaluate whether certain sales taxes and other similar taxes are lessor or lessee costs, and instead account for those costs as if they are lessee costs. Additionally, the standard clarifies that lessors should account for costs excluded from the consideration of a contract that are paid by the lessor and reimbursed by the lessee as revenue. Early adoption of these standards is permitted. We are currently in the process of evaluating the impact of the amended guidance on our Condensed Consolidated Financial Statements. In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment . This standard eliminates Step 2 of the goodwill impairment test and requires a goodwill impairment to be measured as the amount by which a reporting unit’s carrying amount exceeds its fair value, not to exceed the carrying amount of its goodwill. ASU 2017-04 is effective for our first quarter of fiscal 2021 and requires a prospective transition method. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement . The purpose of the standard is to improve the overall usefulness of fair value disclosures to financial statement users and reduce unnecessary costs to companies when preparing the disclosures. ASU 2018-13 is effective for our first quarter of fiscal 2021. ASU 2018-13 requires application of the prospective method of transition (for only the most recent interim or annual period presented in the initial fiscal year of adoption) to the new disclosure requirements for (1) changes in unrealized gains and losses included in other comprehensive income and (2) the range and weighted average used to develop significant unobservable inputs for Level 3 fair value measurements. ASU 2018-13 also requires prospective application to any modifications to disclosures made because of the change to the requirements for the narrative description of measurement uncertainty. The effects of all other amendments made by ASU 2018-13 must be applied retrospectively to all periods presented. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. In August 2018, the FASB issued ASU 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Topic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans. The purpose of the standard is to improve the overall usefulness of defined benefit pension and other postretirement plan disclosures to financial statement users and reduce unnecessary costs to companies when preparing the disclosures. ASU 2018-14 is effective for our fourth quarter of fiscal 2021 and requires a retrospective transition method. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract . The update aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). ASU 2018-15 is effective for our first quarter of fiscal 2021 and allows a retrospective or a prospective transition method to all implementation costs incurred after the date of adoption. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. In October 2018, the FASB issued ASU 2018-16, Derivatives and Hedging (Topic 815): Inclusion of the Secured Overnight Financing Rate (SOFR) Overnight Index Swap (OIS) Rate as a Benchmark Interest Rate for Hedge Accounting Purposes. The purpose of the standard is to allow the use of the OIS rate based on the SOFR for hedge accounting purposes, which allows entities to designate changes in the fair values of fixed-rate financial assets or liabilities attributable to the OIS rate as the hedged risk. ASU 2018-16 is effective for our first quarter of fiscal 2020 and requires a prospective application. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. In November 2018, the FASB issued ASU 2018-18, Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606 . The purpose of the standard is to (1) clarify that transactions between participants in a collaborative agreement should be accounted for under Topic 606 and (2) add unit-of-account guidance in Topic 808 to align with Topic 606. ASU 2018-18 is effective for our first quarter of fiscal 2020 and must be applied retrospectively to the first quarter of fiscal 2019, the date of initial application of Topic 606. Early adoption is permitted. We are currently in the process of evaluating the impact of adoption on our Condensed Consolidated Financial Statements. Except as noted above, there have been no significant changes to our assessment of the impact of recently issued accounting standards included in Note 1 of our Consolidated Financial Statements in our 2018 Form 10-K .

Revenue Recognition (Notes)

Revenue Recognition (Notes)	3 Months Ended
	Dec. 31, 2018
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer [Text Block]	Revenue Recognition On October 1, 2018, we adopted ASC 606 using the modified retrospective method for contracts that were not completed as of the adoption date. The cumulative effect of initially applying ASC 606 was an adjustment to decrease the opening balance of Retained earnings by $4.9 million , which is net of a $4.8 million tax effect, as of October 1, 2018. Prior period amounts are not adjusted and continue to be reported in accordance with our historical revenue recognition policies. Consistent with prior practice, revenue is presented in the Condensed Consolidated Statements of Income net of sales discounts and allowances, GPO fees, price concessions, rebates and customer returns for product sales and rental revenue reserves. Prior to our adoption of ASC 606, we recognized revenue when the following criteria were met: evidence of an arrangement existed; delivery had occurred; the selling price was fixed or determinable and collection was considered probable. Following our adoption of ASC 606, we recognize revenue when we satisfy a performance obligation by transferring a promised good or service to a customer, as defined by the customer contract. We elected to use the significant financing practical expedient under which the impacts of financing are considered immaterial if the duration of the financing is one year or less. Generally, customer payments are due within 30 days of invoice, though in some countries and for certain customer types, credit terms are longer based on local industry practices. Revenue related to certain products within our Patient Support Systems segment is required to be recognized later under ASC 606 than it was historically due to the determination that the performance obligation was a fully installed system. Historically, this obligation was accounted for as a multiple element arrangement and revenue was recognized upon delivery of hardware and software and the remainder when installation was complete. As a result of the deferral of the recognition of revenue, adoption date adjustments were required to be recorded related to deferred contract costs and equipment and other costs, which is reported in Other current assets. Additionally, cash received from customers at inception of open contracts or billing that preceded satisfaction of remaining performance obligations is recorded as Deferred revenue in Other current liabilities and Other long-term liabilities. Revenue related to certain products within our Front Line Care segment is required to be accelerated under ASC 606 compared to historical practice. This outcome is attributable to the conclusion that we have no on-going performance obligation after delivery of the product to the customer, whereas previously this revenue was recognized over the reimbursement period. As a result of the accelerated recognition of revenue, adoption date adjustments were required to be recorded to Trade accounts receivable, net of allowances and to derecognize assets previously recorded. The cumulative effect of the changes made on the Condensed Consolidated Balance Sheets at October 1, 2018 for the adoption of ASC 606, is as follows: Impacted Condensed Consolidated Balance Sheet Items September 30, 2018 As Reported Impacts of ASC 606 Adoption October 1, 2018 After 606 Adoption ASSETS Trade accounts receivable, net of allowances $ 580.7 $ 29.1 $ 609.8 Other current assets 100.2 21.8 122.0 Property, plant and equipment, net 328.3 (5.6 ) 322.7 Deferred income taxes 35.0 5.6 40.6 Other assets 75.1 3.4 78.5 LIABILITIES Deferred revenue 40.0 47.5 87.5 Other current liabilities 67.1 0.8 67.9 Other long-term liabilities 40.4 10.9 51.3 SHAREHOLDERS ’ EQUITY Retained earnings 1,876.2 (4.9 ) 1,871.3 The impacts of the adoption of ASC 606 in the quarter ended December 31, 2018 on our Condensed Consolidated Statement of Income are shown below. Quarter Ended December 31, 2018 Impacted Condensed Consolidated Statement of Income Items As Reported Impacts of ASC 606 Adoption Balances without ASC 606 Adoption Product sales and service net revenue 1 $ 611.6 $ 24.0 $ 587.6 Rental net revenue 1 71.9 (24.7 ) 96.6 Cost of goods sold 2 316.3 5.4 310.9 Rental expenses 2 37.2 (5.6 ) 42.8 Income tax expense (benefit) 7.4 (0.1 ) 7.5 Net income 42.2 (0.4 ) 42.6 1 Includes $24.2 million related to revenue previously classified as Rental revenue that has been reclassified to Product sales and service revenue as a result of the adoption of ASC 606. 2 Includes $5.1 million related to cost of goods sold previously classified as Rental expenses that has been reclassified to Cost of goods sold as a result of the adoption of ASC 606. Within our Patient Support Systems segment, the adoption of ASC 606 impacted equipment and other costs which is reported in Other current assets and deferred revenue which is reported in Other long-term liabilities. Within our Front Line Care segment, the adoption of ASC 606 impacted the reported amount in Trade accounts receivable, net of allowances and results in the derecognition of assets previously recorded. The impacts of the adoption of ASC 606 as of December 31, 2018, including the cumulative effects of the change, on our Condensed Consolidated Balance Sheet are shown below. December 31, 2018 Impacted Condensed Consolidated Balance Sheet Items As Reported Impacts of ASC 606 Adoption Balances without ASC 606 Adoption ASSETS Trade accounts receivable, net of allowances $ 537.9 $ 29.6 $ 508.3 Other current assets 114.3 22.5 91.8 Property, plant and equipment, net 316.2 (6.1 ) 322.3 Deferred income taxes 34.9 5.6 29.3 Other assets 93.7 3.5 90.2 LIABILITIES Deferred revenue 84.4 48.7 35.7 Other current liabilities 71.6 0.7 70.9 Other long-term liabilities 75.1 11.1 64.0 SHAREHOLDERS ’ EQUITY Retained earnings 1,899.9 (4.9 ) 1,904.8 Included in other current assets and other assets is equipment and other costs directly related to performance obligations that have not been completed for certain contracts in our Patient Support Systems segment. These costs are subsequently expensed to Cost of goods sold commensurate with the timing of the recognition of revenue, which is generally 12 to 24 months. As of December 31, 2018, we had $20.7 million of equipment and other costs recorded within Other current assets and $3.5 million in Other assets. Deferred Contract Costs Consistent with prior practice, deferred contract costs consist of commissions paid on receipt of a purchase order for certain products in our Patient Support Systems segment. These costs are subsequently expensed to Selling and administrative expenses commensurate with the timing of the recognition of revenue, which is generally 12 to 24 months. As of December 31, 2018, we had $7.9 million of deferred contract costs recorded within Other current assets and Other assets. For the quarter ended December 31, 2018, we amortized $3.4 million of deferred contract costs, which are classified within Selling and administrative expenses in the Condensed Consolidated Statements of Income. Disaggregation of Revenue The impact of the adoption of ASC 606 on the quarter ended December 31, 2018 is provided below. Revenue related to certain products within our Patient Support Systems segment is required to be recognized later under ASC 606 than it was historically due to the determination that the performance obligation was a fully installed system. Historically, this obligation was accounted for as a multiple element arrangement and revenue was recognized upon delivery of hardware and software and the remainder when installation was complete. Revenue related to certain products within our Front Line Care segment is required to be accelerated under ASC 606 compared to historical practice. This outcome is attributable to the conclusion that the we do not have an on-going performance obligation after delivery of the product to the customer, whereas previously this revenue was recognized over the reimbursement period. Quarter Ended December 31, 2018 As Reported Impacts of ASC 606 Adoption Balances without ASC 606 Adoption Net revenue - United States: Patient Support Systems $ 248.1 $ (1.4 ) $ 249.5 Front Line Care 166.5 0.5 166.0 Surgical Solutions 53.9 — 53.9 Total net revenue - United States $ 468.5 $ (0.9 ) $ 469.4 Net revenue - Outside of the United States (“OUS”): Patient Support Systems $ 92.9 $ 0.2 $ 92.7 Front Line Care 66.9 — 66.9 Surgical Solutions 55.2 — 55.2 Total net revenue - OUS $ 215.0 $ 0.2 $ 214.8 Net revenue: Patient Support Systems $ 341.0 $ (1.2 ) $ 342.2 Front Line Care 233.4 0.5 232.9 Surgical Solutions 109.1 — 109.1 Total net revenue $ 683.5 $ (0.7 ) $ 684.2 Contract Balances The nature of our products and services does not give rise to contract assets as we typically do not have instances where a right to payment for goods and services already transferred to a customer exists that is conditional on something other than the passage of time. The following summarizes contract liability activity during the first quarter of fiscal 2019. The contract liability balance as of December 31, 2018 represents the transaction price allocated to the remaining performance obligations. Contract Liabilities Balance as of September 30, 2018 $ 47.8 Revenue deferred due to ASC 606 initial adoption 58.4 New revenue deferrals 58.6 Revenue recognized upon satisfaction of performance obligations (55.9 ) Balance as of December 31, 2018 $ 108.9 We expect to satisfy the majority of the remaining performance obligations related to installation and recognize the associated revenue in approximately 12 months. We expect to satisfy the majority of the remaining performance obligations related to service contracts and recognize the associated revenue generally within 24 months.

Supplementary Balance Sheet Inf

Supplementary Balance Sheet Information	3 Months Ended
	Dec. 31, 2018
Balance Sheet Related Disclosures [Abstract]
Supplementary Balance Sheet Information	Supplementary Balance Sheet Information December 31, September 30, Allowance for possible losses and discounts on trade receivables $ 22.4 $ 21.8 Inventories, net of reserves: Finished products $ 140.7 $ 139.7 Raw materials and work in process 159.2 152.0 Total inventories, net of reserves $ 299.9 $ 291.7 Accumulated depreciation of property, plant and equipment $ 569.2 $ 586.7 Accumulated amortization of software and other intangible assets $ 558.6 $ 532.8 Investments included in Other assets $ 50.9 $ 24.6 Preferred stock, without par value: Shares authorized 1,000,000 1,000,000 Shares issued None None Common stock, without par value: Shares authorized 199,000,000 199,000,000 Shares issued 88,457,634 88,457,634 Shares outstanding 66,657,887 67,256,112 Treasury shares 21,799,747 21,201,522 Investments In the first quarter of fiscal 2019, we acquired $26.6 million of non-marketable equity securities that are valued at cost. There has not been any impairment of the historical cost of our investments in non-marketable equity securities.

Acquisitions

Acquisitions - USD ($) $ in Millions	Oct. 01, 2018	Dec. 31, 2018
Business Combinations [Abstract]
Acquisitions		Business Combinations Asset Acquisition On October 1, 2018, we acquired the right to use patented technology and certain related assets from a supplier to our Front Line Care segment. We paid $17.1 million of cash and committed to guaranteed minimum future royalty payments of $22.0 million which are presented in Other intangible assets and software, net and are being amortized over the 7-year term of the agreement. Disposition In fiscal 2017, we sold our Völker business. In the first quarter of fiscal 2018, we recorded a gain of $1.0 million attributable to the final working capital settlement associated with the Völker transaction.
Cash Paid for Asset Acquisition	$ 17.1
Royalty Guarantees, Commitments, Amount		$ 22

Goodwill

Goodwill	3 Months Ended
	Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill The following summarizes goodwill activity by reportable segment: Patient Support Systems Front Line Care Surgical Solutions Total Balances as of September 30, 2018 Goodwill $ 544.4 $ 1,370.6 $ 296.1 $ 2,211.1 Accumulated impairment losses (472.8 ) — — (472.8 ) Goodwill, net as of September 30, 2018 71.6 1,370.6 296.1 1,738.3 Changes in Goodwill in the period: Currency translation effect (0.4 ) (4.1 ) (1.9 ) (6.4 ) Balances as of December 31, 2018 Goodwill 544.0 1,366.5 294.2 2,204.7 Accumulated impairment losses (472.8 ) — — (472.8 ) Goodwill, net as of December 31, 2018 $ 71.2 $ 1,366.5 $ 294.2 $ 1,731.9

Financing Agreements

Financing Agreements	3 Months Ended
	Dec. 31, 2018
Debt Disclosure [Abstract]
Financing Agreements	Financing Agreements Total debt consists of the following: December 31, September 30, Revolving credit facility, matures September 2021 $ 25.0 $ — Current portion of long-term debt 0.1 0.1 Senior secured Term Loan A, long-term portion, matures September 2021 1,030.5 1,029.7 Senior unsecured 5.75% notes due on September 1, 2023 421.0 420.8 Senior unsecured 5.00% notes due on February 15, 2025 296.5 296.4 Unsecured 7.00% debentures due on February 15, 2024 13.5 13.6 Unsecured 6.75% debentures due on December 15, 2027 29.6 29.5 Securitization Program 110.0 110.0 Note Securitization Facility 78.3 72.4 Other 0.4 0.4 Total debt 2,004.9 1,972.9 Less Short-term borrowings 188.4 182.5 Total Long-term debt $ 1,816.5 $ 1,790.4 In May 2018, we renewed our 364 -day accounts receivable securitization program (the “Securitization Program”) with certain financial institutions for borrowings up to $110.0 million . We also entered into an additional 364 -day facility for borrowings up to $90.0 million (the “Note Securitization Facility”) in May 2018. Under the terms of each of the Securitization Program and Note Securitization Facility, certain of our accounts receivable secure the amounts borrowed and cannot be used to pay our other debts or liabilities. The amount that we may borrow at a given point in time is determined based on the amount of qualifying accounts receivable that are present at such point in time. As of December 31, 2018 , $110.0 million and $78.3 million were borrowed under the Securitization Program and Note Securitization Facility. Borrowings outstanding under the Securitization Program and Note Securitization Facility bear interest at the London Interbank Offered Rate (“LIBOR”) plus the applicable margin of 0.8% and 1.0% and are included as a component of Short-term borrowings, while the accounts receivable securing these obligations remain as a component of Trade accounts receivable, net of allowances, in our Condensed Consolidated Balance Sheets. In addition, the agreements governing the Securitization Program and Note Securitization Facility contain various customary affirmative and negative covenants, and customary default and termination provisions. As of December 31, 2018 , we were in compliance with these covenants and provisions. We have outstanding senior unsecured notes of $300.0 million maturing February 2025 that bear interest at a fixed rate of 5.00% annually, and senior unsecured notes of $425.0 million maturing in September 2023 that bear interest at a fixed rate of 5.75% annually (collectively, the “Senior Notes”). These Senior Notes were issued at par in private placement offerings and are not registered securities on any public market. All of the notes were outstanding as of December 31, 2018 . We are not required to make any mandatory redemption or sinking fund payments with respect to the Senior Notes, other than in certain circumstances such as a change in control or material sale of assets. We may redeem the 5.00% and 5.75% notes prior to maturity, but doing so prior to February 15, 2025 and September 1, 2023, respectively, would require payment of a premium on any amounts redeemed, the amount of which varies based on the timing of the redemption. The indentures governing the Senior Notes contain certain covenants which impose limitations on the amount of dividends we may pay and the amount of common shares we may repurchase in the open market, but we do not expect these covenants to affect our current dividend policy or open share repurchase program. The terms of these indentures also impose certain restrictions on the amount and type of additional indebtedness we may obtain in the future, as well as the types of liens and guarantees we may provide. Our Senior Credit Agreement consists of two facilities as follows: • $1,462.5 million senior secured Term Loan A facility (“TLA Facility”), maturing in September 2021 • Revolving Credit Facility providing borrowing capacity of up to $700.0 million , maturing in September 2021 The TLA Facility and Revolving Credit Facility bear interest at variable rates which currently approximate 4.1% . These interest rates are based primarily on LIBOR, but under certain conditions could also be based on the U.S. Federal Funds Rate or the U.S. Prime Rate, at our option. We are able to voluntarily prepay outstanding loans under the TLA Facility at any time. In the quarter ended December 31, 2018 , we did not make any payments on the TLA Facility. As of December 31, 2018 , there were outstanding borrowings of $25.0 million on the Revolving Credit Facility, and available borrowing capacity was $667.0 million after giving effect to $8.0 million of outstanding standby letters of credit. The availability of borrowings under our Revolving Credit Facility is subject to our ability at the time of borrowing to meet certain specified conditions, including compliance with covenants contained in the Senior Credit Agreement. The facilities provided by the Senior Credit Agreement are held with a syndicate of banks, which includes over 30 institutions. Our general corporate assets, including those of certain of our subsidiaries, collateralize these obligations. The credit agreement governing these facilities contains financial covenants which specify a maximum secured net leverage ratio and a minimum interest coverage ratio, as such terms are defined in the credit agreement. These financial covenants are measured at the end of each fiscal quarter. The required ratios vary providing a gradually decreasing maximum secured net leverage ratio and a gradually increasing minimum interest coverage ratio, as set forth in the table below: Any Fiscal Quarter Ended in the Calendar Year Ending: Maximum Minimum December 31, 2018 3.50x 3.75x December 31, 2019 and thereafter 3.00x 4.00x We were in compliance with all financial covenants under our financing agreements as of December 31, 2018 . We are exposed to market risk from fluctuations in interest rates. We sometimes manage our exposure to interest rate fluctuations through the use of interest rate swaps. As of December 31, 2018 , we had five interest rate swap agreements, with notional amounts of $750.0 million , in aggregate, to hedge the variability of cash flows associated with a portion of the variable interest rate payments through September 2021 on the Senior Credit Agreement. The interest rate swaps have effective start dates ranging between December 31, 2018 and September 8, 2020 and were designated as cash flow hedges. As of December 31, 2018 and September 30, 2018 , these swaps were in a net asset position with an aggregate fair value of $13.0 million and $24.8 million , all of which were classified as Other assets. We classify fair value measurements on our interest rate swaps as Level 2, as described in Note 1. In July 2018, we entered into two cross-currency swap agreements, with an aggregate notional amount of $198.7 million to hedge the variability of U.S. dollar-Euro exchange rates through July 2023. These cross-currency swaps are designated as net investment hedges of subsidiaries using Euro as their functional currency. We entered into these cross-currency swaps to mitigate changes in net assets due to changes in U.S. dollar-Euro spot exchange rates. As of December 31, 2018 , these swaps were in a net asset position with an aggregate fair value of $5.6 million which was classified as Other assets. As of September 30, 2018, these swaps were in a net liability position with an aggregate fair value of $1.2 million which was classified as Other current liabilities. We classify fair value measurements on our cross-currency swaps as Level 2, as described in Note 1. We assess hedge effectiveness under the spot-to-spot method and record changes in fair value attributable to the translation of foreign currencies through Accumulated other comprehensive income (loss). We amortize the impact of all other changes in fair value of the derivative through Interest expense. The fair value of our debt is estimated based on the quoted market prices for the same or similar issues or on the current rates offered to us for debt of the same remaining maturities. The book values of our variable rate short-term debt instruments and Revolving Credit Facility approximate fair value. The estimated fair values of our long-term debt instruments are described in the table below: December 31, September 30, Senior secured Term Loan A $ 995.8 $ 991.9 Senior unsecured 5.75% notes due on September 1, 2023 426.9 437.3 Senior unsecured 5.00% notes due on February 14, 2025 287.4 294.0 Unsecured debentures 41.1 42.9 Total $ 1,751.2 $ 1,766.1 The estimated fair values of our long-term unsecured debentures were based on observable inputs such as quoted prices in markets that are not active. The estimated fair values of our term loans and the Senior Notes were based on quoted prices for similar liabilities. These fair value measurements are classified as Level 2, as described in Note 1.

Retirement and Postretirement P

Retirement and Postretirement Plans	3 Months Ended
	Dec. 31, 2018
Retirement Benefits [Abstract]
Retirement and Postretirement Plans	Retirement and Postretirement Plans We sponsor five defined benefit retirement plans. Those plans include a master defined benefit retirement plan in the United States, a nonqualified supplemental executive defined benefit retirement plan, and three defined benefit retirement plans covering employees in Germany and France. Benefits for such plans are based primarily on years of service and the employee’s level of compensation in specific periods of employment. We contribute funds to trusts as necessary to provide for current service and for any unfunded projected future benefit obligation over a reasonable period of time. All of our plans have a September 30 measurement date. The following table details the components of net pension expense for our defined benefit retirement plans. Quarter Ended December 31 Condensed Consolidated Statements of Income Item 2018 2017 Service cost $ 0.3 $ 0.3 Cost of goods sold Service cost 0.8 0.9 Selling and administrative expenses Interest cost 3.1 2.7 Investment income and other, net Expected return on plan assets (3.7 ) (3.9 ) Investment income and other, net Amortization of net loss 0.6 1.2 Investment income and other, net Net pension expense $ 1.1 $ 1.2 In addition to defined benefit retirement plans, we also offer two postretirement health care plans in the United States that provide health care benefits to qualified retirees and their dependents. The plans are closed to new participants and include retiree cost sharing provisions and generally extends retiree coverage for medical and prescription benefits beyond the COBRA continuation period to the date of Medicare eligibility. Annual costs related to these plans are not significant. We have defined contribution savings plans that cover substantially all U.S. employees and certain non-U.S. employees. The general purpose of these plans is to provide additional financial security in retirement by providing employees with an incentive to make regular savings. Our contributions to the plans are based on eligibility and, in some cases, employee contributions. Expense under these plans was $6.2 million and $6.4 million in each of the quarterly periods ended December 31, 2018 and 2017 .

Other Comprehensive Income (Los

Other Comprehensive Income (Loss)	3 Months Ended
	Dec. 31, 2018
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other Comprehensive Income (Loss)	Other Comprehensive Income (Loss) The following tables represents the changes in Accumulated other comprehensive income (loss) by component: Quarter Ended December 31, 2018 Other comprehensive income (loss) Prior to reclassification Reclassification from Pre-tax Tax effect Net of tax Derivative instruments and hedges: Foreign exchange forward contracts 1 $ 1.2 $ (0.1 ) $ 1.1 $ (0.4 ) $ 0.7 Interest rate swaps 2 (5.1 ) (2.1 ) (7.2 ) 1.9 (5.3 ) Cross-currency swaps 2 2.2 — 2.2 (1.3 ) 0.9 Derivative instruments and hedges total (1.7 ) (2.2 ) (3.9 ) 0.2 (3.7 ) Foreign currency translation adjustment (13.6 ) — (13.6 ) — (13.6 ) Change in pension and postretirement defined benefit plans — 0.5 0.5 (0.1 ) 0.4 Total $ (15.3 ) $ (1.7 ) $ (17.0 ) $ 0.1 $ (16.9 ) December 31, 2018 Accumulated other comprehensive income (loss) Beginning Impacts of ASU 2018-02 Adoption Net activity Ending 3 Derivative instruments and hedges: Foreign exchange forward contracts 1 $ 0.2 $ — $ 0.7 $ 0.9 Interest rate swaps 2 18.3 0.8 (5.3 ) 13.8 Cross-currency swaps 2 (1.7 ) — 0.9 (0.8 ) Derivative instruments and hedges total 16.8 0.8 (3.7 ) 13.9 Foreign currency translation adjustment (105.3 ) — (13.6 ) (118.9 ) Change in pension and postretirement defined benefit plans (24.5 ) (6.2 ) 0.4 (30.3 ) Total $ (113.0 ) $ (5.4 ) $ (16.9 ) $ (135.3 ) 1 We are subject to variability in foreign currency exchange rates due to our international operations. Exposure to this variability is periodically managed primarily through the use of natural hedges, whereby funding obligations and assets are both managed in the local currency. From time-to-time, we enter into currency exchange agreements to manage our exposure arising from fluctuating exchange rates related to specific and projected transactions. We operate this program pursuant to documented corporate risk management policies and do not enter into derivative transactions for speculative purposes. The sensitivity of earnings and cash flows to variability in exchange rates is assessed by applying an appropriate range of potential rate fluctuations to our assets, obligations and projected results of operations denominated in foreign currencies. Our currency risk consists primarily of foreign currency denominated firm commitments and projected foreign currency denominated intercompany and third-party transactions. As of December 31, 2018 , the notional amount of open foreign exchange contracts was $69.9 million . These contracts were in a net asset position reported in Other current assets with a fair value of $1.7 million . The maximum length of time over which we hedge transaction exposures is generally 15 months. Derivative gains and losses, initially reported as a component of Accumulated other comprehensive income (loss), are reclassified to earnings in the period when the transaction affects earnings. 2 See Note 6 for information related to our interest rate and cross-currency swap agreements. 3 The estimated net amount of gains and losses that are reported in Accumulated other comprehensive income (loss) as of December 31, 2018 that is expected to be reclassified into earnings within the next 12 months is $5.2 million . Quarter Ended December 31, 2017 Other comprehensive income (loss) Accumulated other comprehensive income (loss) Prior to reclassification Reclassification from Pre-tax Tax effect Net of tax Beginning balance Net activity Ending balance Derivative instruments and hedges: Foreign exchange forward contracts $ (0.9 ) $ 0.4 $ (0.5 ) $ 0.1 $ (0.4 ) $ (0.4 ) $ (0.4 ) $ (0.8 ) Interest rate swaps 6.7 (0.8 ) 5.9 (2.1 ) 3.8 4.7 3.8 8.5 Derivative instruments and hedges total 5.8 (0.4 ) 5.4 (2.0 ) 3.4 4.3 3.4 7.7 Foreign currency translation adjustment 6.1 — 6.1 — 6.1 (81.3 ) 6.1 (75.2 ) Change in pension and postretirement defined benefit plans (0.1 ) 1.2 1.1 (0.3 ) 0.8 (33.0 ) 0.8 (32.2 ) Total $ 11.8 $ 0.8 $ 12.6 $ (2.3 ) $ 10.3 $ (110.0 ) $ 10.3 $ (99.7 ) The following table represents the items reclassified out of Accumulated other comprehensive income (loss) and the related tax effects: Quarter Ended December 31 2018 2017 Amount Tax effect 4 Net of tax Amount reclassified Tax effect Net of tax Derivative instruments and hedges: Foreign exchange forward contracts 1 $ (0.1 ) $ 0.1 $ — $ 0.4 $ (0.1 ) $ 0.3 Interest rate swaps 2 (2.1 ) 0.6 (1.5 ) (0.8 ) 0.3 (0.5 ) Derivative instruments and hedges total (2.2 ) 0.7 (1.5 ) (0.4 ) 0.2 (0.2 ) Change in pension and postretirement defined benefit plans 3 0.5 (6.3 ) (5.8 ) 1.2 (0.3 ) 0.9 1 Reclassified from Accumulated other comprehensive income (loss) into Investment income and other, net . 2 Reclassified from Accumulated other comprehensive income (loss) into Interest expense . 3 Reclassified from Accumulated other comprehensive income (loss) into Cost of goods sold , Selling and administrative expenses and Investment income and other, net . These components are included in the computation of net periodic pension expense. 4 As a result of the adoption of ASU 2018-02, we reclassified $5.4 million from Accumulated other comprehensive income (loss) to Retained earnings.

Special Charges

Special Charges	3 Months Ended
	Dec. 31, 2018
Special Charges [Abstract]
Special Charges	Special Charges In connection with various organizational changes to improve our business alignment and cost structure, we recognized Special charges of $ 8.0 million and $ 13.5 million for the quarters ended December 31, 2018 and 2017 . We continue to evaluate additional actions related to these programs and expect additional Special charges to be incurred. However, it is not practicable to estimate the amount of these future expected costs until such time as the evaluations are complete. These charges are summarized as follows: Business Optimization In fiscal 2018, we initiated a global transformation program focused on reducing complexity, increasing efficiency, improving our cost structure with targeted investments that align with our strategic priorities. For the quarter ended December 31, 2018 , this program resulted in charges of $3.8 million , of which $2.7 million were severance and benefit costs with the remainder related to professional fees and project management costs. These amounts compare to charges of $9.1 million in the quarter ended December 31, 2017 , of which $6.0 million were severance and benefit costs. Site Consolidation In fiscal 2015, we initiated a plan to streamline our operations and simplify our supply chain by consolidating certain manufacturing and distribution operations (“Site Consolidation”). As part of this action, we have announced the closure of eight sites. In the quarter ended December 31, 2018 , we recorded charges of $4.1 million related to these efforts, primarily comprising lease termination and facility closure costs. This amount compares to charges of $4.1 million in the quarter ended December 31, 2017 , of which $0.2 million were severance and benefit costs. Since the inception of the Site Consolidation program through December 31, 2018 , we have recognized aggregate Special charges of $54.9 million . Integration and Business Realignment As we acquire businesses, we initiate integration activities and position our existing businesses to capitalize on opportunities for growth. We also incur costs, including severance and benefit costs, associated with other business realignment and integration activities. In the quarter ended December 31, 2018 , we incurred integration and business realignment charges of approximately $0.1 million . This amount compares to charges of $0.3 million in the quarter ended December 31, 2017 . For all accrued severance and other benefit charges described above, we record restructuring reserves within Other current liabilities. The reserve activity for severance and other benefits in the quarter ended December 31, 2018 was as follows: Balance as of September 30, 2018 $ 8.5 Expenses 3.2 Cash Payments (6.2 ) Reversals (0.5 ) Balance as of December 31, 2018 $ 5.0

Income Taxes

Income Taxes	3 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The effective tax rate for the quarter ended December 31, 2018 was 14.9% compared to (186.7)% for the quarter ended December 31, 2017. The effective tax rate for the current period is higher than the comparable period due primarily to tax benefits recorded in the prior period related to the Tax Act. The current period rate was favorably impacted by $3.1 million of discrete tax benefits primarily related to excess tax benefits on deductible stock compensation and a $1.0 million benefit from the Transition Tax adjustment discussed further below. This compares to $64.3 million of discrete tax benefits in the prior year primarily related to the Tax Act, including $2.9 million of excess tax benefits on deductible stock compensation. On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Act. The Tax Act made broad and complex changes to the U.S. tax code which impacted our fiscal year ended September 30, 2018, and continues to impact our first quarter ended December 31, 2018 , including, but not limited to (1) reducing the U.S. Federal corporate tax rate, (2) requiring a one-time transition tax on certain unrepatriated earnings of foreign subsidiaries that may electively be paid over eight years, and (3) accelerated first year expensing of certain capital expenditures. The Tax Act reduced the U.S. Federal corporate tax rate from 35.0% to 21.0% effective January 1, 2018 for calendar year tax filers. In accordance with Internal Revenue Code Section 15, our fiscal year ended September 30, 2018 had a blended corporate tax rate of 24.5% , which was based on a proration of the applicable tax rates before and after the effective date of the Tax Act. The statutory tax rate of 21.0% applies to our current fiscal 2019. The Tax Act also put in place new tax laws that will impact our taxable income in fiscal 2019, which include, but are not limited to (1) creating a Base Erosion Anti-abuse Tax (“BEAT”), which is a tax on certain related-party payments that reduce the U.S. tax base, (2) generally eliminating U.S. Federal income taxes on dividends from foreign subsidiaries, (3) a new provision designed to tax currently global intangible low-taxed income (“GILTI”), which allows for the possibility of utilizing foreign tax credits and a deduction equal to 50.0% to offset the income tax liability (subject to some limitations), (4) a provision that could limit the amount of deductible interest expense, (5) the repeal of the domestic production activity deduction replaced with an additional deduction for foreign-derived intangible income (“FDII”), (6) limitations on the deductibility of certain executive compensation, and (7) limitations on the utilization of foreign tax credits to reduce the U.S. income tax liability. Shortly after the Tax Act was enacted, the SEC staff issued Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (“SAB 118”) which provides guidance on accounting for the Tax Act’s impact. SAB 118 provided a measurement period, which in no case should extend beyond one year from the Tax Act enactment date, during which a company acting in good faith may complete the accounting for the impacts of the Tax Act under ASC Topic 740. In accordance with the expiration of the SAB 118 measurement period, we completed the assessment of the income tax effects of the Tax Act in the first quarter of fiscal 2019. As of September 30, 2018, we recorded a provisional discrete net tax benefit of $70.9 million related to the Tax Act. This net benefit primarily consisted of a net benefit of $93.8 million due to the remeasurement of our deferred tax accounts to reflect the corporate rate reduction impact to our net deferred tax balances and a net expense for the Transition Tax of $22.9 million . In finalizing our net tax benefit resulting from the Tax Act within the one-year window as provided in SAB 118, we further reduced our Transition Tax liability by $1.0 million in the first quarter of fiscal 2019. Reduction in U.S. Federal corporate rate: The Tax Act reduced the U.S. Federal statutory corporate tax rate to 21.0% for fiscal 2019 and beyond. We recorded a provisional adjustment to our net deferred tax balances, with a corresponding discrete net tax benefit of $93.8 million during fiscal 2018. We have completed our analysis of the impact of the U.S Federal statutory corporate tax rate change and no further adjustments to the provisional amounts were required in the first quarter of fiscal 2019. Transition Tax: The Transition Tax is a fiscal 2018 tax on the previously untaxed accumulated and current earnings and profits (“E&P”) of our foreign subsidiaries. In order to determine the amount of the Transition Tax, we must determine, in addition to other factors, the amount of post-1986 E&P of the relevant subsidiaries, as well as the amount of non-U.S. income taxes paid on such earnings. E&P is similar to retained earnings of the subsidiary, but requires other adjustments to conform to U.S. tax rules. During the first quarter of fiscal 2019, we finalized our estimate for Transition Tax and reduced the Transition Tax liability by $1.0 million to a total of $21.9 million . This liability was calculated based on the current statute as well as taking into account interpretative guidance provided as of the end of first quarter of fiscal year 2019. On January 15, 2019, the U.S. Internal Revenue Service and Treasury Department released final regulations related to the Transition Tax that clarifies the required treatment of certain items. We are in the process of evaluating the impact of these regulations on our related tax positions. GILTI: The Tax Act includes a provision designed to currently tax global intangible low-taxed income starting in fiscal 2019. We have made an accounting policy election to treat the impacts of the GILTI tax provisions as period costs in the period incurred. As such, we have not recorded deferred tax assets or liabilities with respect to the GILTI provisions. As of September 30, 2018, our practice and intention was to reinvest the earnings in our non-U.S. subsidiaries outside of the United States, and no U.S. deferred income taxes or foreign withholding taxes were recorded. The Transition Tax noted above resulted in the previously untaxed foreign earnings being included in the U.S. Federal and state fiscal 2018 taxable income. Furthermore, the Transition Tax will close a majority of the outside basis differences in our foreign corporations and any remaining temporary difference will potentially have some interaction with the GILTI tax noted above. Based on a review of our global working capital requirements and analysis of the new tax laws, we made no changes to our permanent reinvestment assertions pursuant to APB 23, to reinvest the earnings in our non-U.S. subsidiaries outside of the United States. Thus, no U.S. deferred income taxes or foreign withholding taxes have been recorded.

Earnings per Common Share

Earnings per Common Share	3 Months Ended
	Dec. 31, 2018
Earnings Per Share [Abstract]
Earnings per Common Share	Earnings per Common Share Basic earnings per share is calculated based upon the weighted average number of outstanding common shares for the period, plus the effect of deferred vested shares. Diluted earnings per share is calculated consistent with the basic earnings per share calculation plus the effect of dilutive unissued common shares related to stock-based employee compensation programs. For all periods presented, anti-dilutive stock options were excluded from the calculation of diluted earnings per share. Cumulative treasury stock acquired, less cumulative shares reissued, have been excluded in determining the average number of shares outstanding. Earnings per share are calculated as follows (share information in thousands): Quarter Ended December 31 2018 2017 Net income $ 42.2 $ 88.3 Average basic shares outstanding 67,053 65,906 Add potential effect of exercise of stock options and other unvested equity awards 672 1,526 Average diluted shares outstanding 67,725 67,432 Net income per basic common share $ 0.63 $ 1.34 Net income per diluted common share $ 0.62 $ 1.31 Shares with anti-dilutive effect excluded from the computation of diluted EPS 486 233 Diluted earnings per share decreased from $1.31 to $0.62 for the three months ended December 31, 2018 primarily due to the initial recording of the net tax benefit associated with our assessment of the transition impact of the Tax Act in the three months ended December 31, 2017.

Common Stock

Common Stock	3 Months Ended
	Dec. 31, 2018
Class of Stock Disclosures [Abstract]
Common Stock	Common Stock The stock-based compensation cost that was charged against income, net of tax, for all plans was $4.2 million and $4.6 million in the quarterly periods ended December 31, 2018 and 2017 . In connection with employees satisfying payroll tax withholding obligations for restricted stock distributions, we purchased 37,445 shares of our common stock for $3.5 million in the quarter ended December 31, 2018 , and 43,374 shares for $3.5 million in the quarter ended December 31, 2017 . We purchased 792,264 shares of our common stock in the open market under our share repurchase program for $75.0 million in the quarter ended December 31, 2018 . As of December 31, 2018 , a cumulative total of $250.3 million of our share repurchase program had been used, leaving us with the ability to repurchase shares with a value of $89.7 million . This program does not have an expiration date and there are no plans to terminate this program in the future.

Guarantees

Guarantees	3 Months Ended
	Dec. 31, 2018
Product Warranties Disclosures [Abstract]
Guarantees	Guarantees We routinely grant limited warranties on our products with respect to defects in material and workmanship. The terms of these warranties are generally one year, however, certain components and products have substantially longer warranty periods. We recognize a reserve with respect to these obligations at the time of product sale, with subsequent warranty claims recorded directly against the reserve. The amount of the warranty reserve is determined based on historical trend experience for the covered products. For more significant warranty-related matters which might require a broad-based correction, separate reserves are established when such events are identified and the cost of correction can be reasonably estimated. A rollforward of changes in the warranty reserve for the periods covered in this report is as follows: Quarter Ended December 31 2018 2017 Balance as of beginning of period $ 20.5 $ 25.5 Provision for warranties in the period 5.1 3.5 Warranty reserves assumed 1 2.8 — Warranty claims in the period (3.5 ) (3.7 ) Balance as of end of period $ 24.9 $ 25.3 1 As a result of the asset acquisition discussed in Note 4. In the normal course of business, we enter into various other guarantees and indemnities in our relationships with suppliers, service providers, customers, business partners and others. Examples of these arrangements would include guarantees of product performance, indemnifications to service providers and indemnifications of our actions to business partners. These guarantees and indemnifications have not historically had a material impact on our financial condition or results of operations, nor do we expect them to, although indemnifications associated with our actions generally have no dollar limitations. In conjunction with our acquisition and divestiture activities, we have entered into select guarantees and indemnifications of performance with respect to the fulfillment of commitments under applicable purchase and sale agreements. The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract. With respect to sale transactions, we also routinely enter into non-competition agreements for varying periods of time. Guarantees and indemnifications with respect to acquisition and divestiture activities, if triggered, could have a materially adverse impact on our financial condition and results of operations.

Segment Reporting

Segment Reporting	3 Months Ended
	Dec. 31, 2018
Segment Reporting [Abstract]
Segment Reporting	Segment Reporting We disclose segment information that is consistent with the way in which management operates and views the business. Our operating structure contains the following reporting segments: • Patient Support Systems – globally provides our med-surg and specialty bed systems and surfaces, safe patient handling equipment and mobility solutions, as well as our clinical workflow solutions that deliver software and information technologies to improve care and deliver actionable insight to caregivers and patients. • Front Line Care – globally provides patient monitoring and diagnostic technologies, including a diversified portfolio of physical assessment tools that help diagnose, treat and manage a wide variety of illnesses and diseases, as well as a portfolio of vision care and respiratory care devices. • Surgical Solutions – globally provides products that improve surgical safety and efficiency in the operating room including tables, lights, pendants, positioning devices and various other surgical instruments and accessories. Our performance within each reportable segment continues to be measured on a divisional income basis before non-allocated operating and administrative costs, litigation, special charges, acquisition and integration costs, acquisition-related intangible asset amortization, and other unusual events. Divisional income generally represents the division’s gross profit less its direct operating costs along with an allocation of manufacturing and distribution costs, research and development and certain corporate functional expenses. Non-allocated operating costs, administrative costs, and other includes functional expenses that support the entire organization such as administration, finance, legal and human resources, expenses associated with strategic developments, acquisition-related intangible asset amortization, and other events that are not indicative of operating trends. We exclude such amounts from divisional income to allow management to evaluate and understand divisional operating trends. The chief operating decision maker does not receive any asset information by operating segment and, accordingly, we do not report asset information by operating segment. Quarter Ended 2018 2017 Net revenue: Patient Support Systems $ 341.0 $ 334.4 Front Line Care 233.4 224.6 Surgical Solutions 109.1 110.7 Total net revenue $ 683.5 $ 669.7 Divisional income: Patient Support Systems $ 56.7 $ 53.4 Front Line Care 60.1 55.4 Surgical Solutions 11.2 9.7 Other operating costs: Non-allocated operating costs, administrative costs, and other 49.2 52.9 Special charges 8.0 13.5 Operating profit 70.8 52.1 Interest expense (21.3 ) (23.1 ) Investment income and other, net 0.1 1.8 Income before income taxes $ 49.6 $ 30.8

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies General We are subject to various claims and contingencies arising out of the normal course of business, including those relating to governmental investigations and proceedings, commercial transactions, product liability, employee related matters, antitrust, safety, health, taxes, environmental and other matters. Litigation is subject to many uncertainties and the outcome of individual litigated matters is not predictable with assurance. It is possible that some litigation matters for which reserves have not been established could be decided unfavorably to us, and that any such unfavorable decisions could have a material adverse effect on our financial condition, results of operations, and cash flows. Self Insurance We are involved in various claims, including product and general liability, workers’ compensation, auto liability and employment related matters. Such claims in the United States have deductibles and self-insured retentions at various limits up to $1.0 million per occurrence or per claim, depending upon the type of coverage and policy period. International deductibles and self-insured retentions are lower. We are also generally self-insured up to certain stop-loss limits for certain employee health benefits, including medical, drug and dental. Our policy is to estimate reserves based upon a number of factors including known claims, estimated incurred but not reported claims and outside actuarial analysis, which are based on historical information along with certain assumptions about future events. Such estimated reserves are classified as Other current liabilities and Other long-term liabilities within the Condensed Consolidated Balance Sheets.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	3 Months Ended
	Dec. 31, 2018
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]	The cumulative effect of the changes made on the Condensed Consolidated Balance Sheets at October 1, 2018 for the adoption of ASC 606, is as follows: Impacted Condensed Consolidated Balance Sheet Items September 30, 2018 As Reported Impacts of ASC 606 Adoption October 1, 2018 After 606 Adoption ASSETS Trade accounts receivable, net of allowances $ 580.7 $ 29.1 $ 609.8 Other current assets 100.2 21.8 122.0 Property, plant and equipment, net 328.3 (5.6 ) 322.7 Deferred income taxes 35.0 5.6 40.6 Other assets 75.1 3.4 78.5 LIABILITIES Deferred revenue 40.0 47.5 87.5 Other current liabilities 67.1 0.8 67.9 Other long-term liabilities 40.4 10.9 51.3 SHAREHOLDERS ’ EQUITY Retained earnings 1,876.2 (4.9 ) 1,871.3 The impacts of the adoption of ASC 606 in the quarter ended December 31, 2018 on our Condensed Consolidated Statement of Income are shown below. Quarter Ended December 31, 2018 Impacted Condensed Consolidated Statement of Income Items As Reported Impacts of ASC 606 Adoption Balances without ASC 606 Adoption Product sales and service net revenue 1 $ 611.6 $ 24.0 $ 587.6 Rental net revenue 1 71.9 (24.7 ) 96.6 Cost of goods sold 2 316.3 5.4 310.9 Rental expenses 2 37.2 (5.6 ) 42.8 Income tax expense (benefit) 7.4 (0.1 ) 7.5 Net income 42.2 (0.4 ) 42.6 1 Includes $24.2 million related to revenue previously classified as Rental revenue that has been reclassified to Product sales and service revenue as a result of the adoption of ASC 606. 2 Includes $5.1 million related to cost of goods sold previously classified as Rental expenses that has been reclassified to Cost of goods sold as a result of the adoption of ASC 606. The impacts of the adoption of ASC 606 as of December 31, 2018, including the cumulative effects of the change, on our Condensed Consolidated Balance Sheet are shown below. December 31, 2018 Impacted Condensed Consolidated Balance Sheet Items As Reported Impacts of ASC 606 Adoption Balances without ASC 606 Adoption ASSETS Trade accounts receivable, net of allowances $ 537.9 $ 29.6 $ 508.3 Other current assets 114.3 22.5 91.8 Property, plant and equipment, net 316.2 (6.1 ) 322.3 Deferred income taxes 34.9 5.6 29.3 Other assets 93.7 3.5 90.2 LIABILITIES Deferred revenue 84.4 48.7 35.7 Other current liabilities 71.6 0.7 70.9 Other long-term liabilities 75.1 11.1 64.0 SHAREHOLDERS ’ EQUITY Retained earnings 1,899.9 (4.9 ) 1,904.8
Disaggregation of Revenue [Table Text Block]	The impact of the adoption of ASC 606 on the quarter ended December 31, 2018 is provided below. Revenue related to certain products within our Patient Support Systems segment is required to be recognized later under ASC 606 than it was historically due to the determination that the performance obligation was a fully installed system. Historically, this obligation was accounted for as a multiple element arrangement and revenue was recognized upon delivery of hardware and software and the remainder when installation was complete. Revenue related to certain products within our Front Line Care segment is required to be accelerated under ASC 606 compared to historical practice. This outcome is attributable to the conclusion that the we do not have an on-going performance obligation after delivery of the product to the customer, whereas previously this revenue was recognized over the reimbursement period. Quarter Ended December 31, 2018 As Reported Impacts of ASC 606 Adoption Balances without ASC 606 Adoption Net revenue - United States: Patient Support Systems $ 248.1 $ (1.4 ) $ 249.5 Front Line Care 166.5 0.5 166.0 Surgical Solutions 53.9 — 53.9 Total net revenue - United States $ 468.5 $ (0.9 ) $ 469.4 Net revenue - Outside of the United States (“OUS”): Patient Support Systems $ 92.9 $ 0.2 $ 92.7 Front Line Care 66.9 — 66.9 Surgical Solutions 55.2 — 55.2 Total net revenue - OUS $ 215.0 $ 0.2 $ 214.8 Net revenue: Patient Support Systems $ 341.0 $ (1.2 ) $ 342.2 Front Line Care 233.4 0.5 232.9 Surgical Solutions 109.1 — 109.1 Total net revenue $ 683.5 $ (0.7 ) $ 684.2
Contract with Customer, Asset and Liability [Table Text Block]	The following summarizes contract liability activity during the first quarter of fiscal 2019. The contract liability balance as of December 31, 2018 represents the transaction price allocated to the remaining performance obligations. Contract Liabilities Balance as of September 30, 2018 $ 47.8 Revenue deferred due to ASC 606 initial adoption 58.4 New revenue deferrals 58.6 Revenue recognized upon satisfaction of performance obligations (55.9 ) Balance as of December 31, 2018 $ 108.9

Supplementary Balance Sheet I_2

Supplementary Balance Sheet Information (Tables)	3 Months Ended
	Dec. 31, 2018
Balance Sheet Related Disclosures [Abstract]
Supplementary Balance Sheet Information	December 31, September 30, Allowance for possible losses and discounts on trade receivables $ 22.4 $ 21.8 Inventories, net of reserves: Finished products $ 140.7 $ 139.7 Raw materials and work in process 159.2 152.0 Total inventories, net of reserves $ 299.9 $ 291.7 Accumulated depreciation of property, plant and equipment $ 569.2 $ 586.7 Accumulated amortization of software and other intangible assets $ 558.6 $ 532.8 Investments included in Other assets $ 50.9 $ 24.6 Preferred stock, without par value: Shares authorized 1,000,000 1,000,000 Shares issued None None Common stock, without par value: Shares authorized 199,000,000 199,000,000 Shares issued 88,457,634 88,457,634 Shares outstanding 66,657,887 67,256,112 Treasury shares 21,799,747 21,201,522

Goodwill (Tables)

Goodwill (Tables)	3 Months Ended
	Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill Activity	The following summarizes goodwill activity by reportable segment: Patient Support Systems Front Line Care Surgical Solutions Total Balances as of September 30, 2018 Goodwill $ 544.4 $ 1,370.6 $ 296.1 $ 2,211.1 Accumulated impairment losses (472.8 ) — — (472.8 ) Goodwill, net as of September 30, 2018 71.6 1,370.6 296.1 1,738.3 Changes in Goodwill in the period: Currency translation effect (0.4 ) (4.1 ) (1.9 ) (6.4 ) Balances as of December 31, 2018 Goodwill 544.0 1,366.5 294.2 2,204.7 Accumulated impairment losses (472.8 ) — — (472.8 ) Goodwill, net as of December 31, 2018 $ 71.2 $ 1,366.5 $ 294.2 $ 1,731.9

Financing Agreements (Tables)

Financing Agreements (Tables)	3 Months Ended
	Dec. 31, 2018
Debt Disclosure [Abstract]
Schedule of Total Debt	Total debt consists of the following: December 31, September 30, Revolving credit facility, matures September 2021 $ 25.0 $ — Current portion of long-term debt 0.1 0.1 Senior secured Term Loan A, long-term portion, matures September 2021 1,030.5 1,029.7 Senior unsecured 5.75% notes due on September 1, 2023 421.0 420.8 Senior unsecured 5.00% notes due on February 15, 2025 296.5 296.4 Unsecured 7.00% debentures due on February 15, 2024 13.5 13.6 Unsecured 6.75% debentures due on December 15, 2027 29.6 29.5 Securitization Program 110.0 110.0 Note Securitization Facility 78.3 72.4 Other 0.4 0.4 Total debt 2,004.9 1,972.9 Less Short-term borrowings 188.4 182.5 Total Long-term debt $ 1,816.5 $ 1,790.4
Schedule of Facilities Covenants	The required ratios vary providing a gradually decreasing maximum secured net leverage ratio and a gradually increasing minimum interest coverage ratio, as set forth in the table below: Any Fiscal Quarter Ended in the Calendar Year Ending: Maximum Minimum December 31, 2018 3.50x 3.75x December 31, 2019 and thereafter 3.00x 4.00x
Schedule of Fair Values of Long-Term Debt Instruments	The estimated fair values of our long-term debt instruments are described in the table below: December 31, September 30, Senior secured Term Loan A $ 995.8 $ 991.9 Senior unsecured 5.75% notes due on September 1, 2023 426.9 437.3 Senior unsecured 5.00% notes due on February 14, 2025 287.4 294.0 Unsecured debentures 41.1 42.9 Total $ 1,751.2 $ 1,766.1

Retirement and Postretirement_2

Retirement and Postretirement Plans (Tables)	3 Months Ended
	Dec. 31, 2018
Retirement Benefits [Abstract]
Schedule of Components of Net Pension Expense	The following table details the components of net pension expense for our defined benefit retirement plans. Quarter Ended December 31 Condensed Consolidated Statements of Income Item 2018 2017 Service cost $ 0.3 $ 0.3 Cost of goods sold Service cost 0.8 0.9 Selling and administrative expenses Interest cost 3.1 2.7 Investment income and other, net Expected return on plan assets (3.7 ) (3.9 ) Investment income and other, net Amortization of net loss 0.6 1.2 Investment income and other, net Net pension expense $ 1.1 $ 1.2

Other Comprehensive Income (L_2

Other Comprehensive Income (Loss) (Tables)	3 Months Ended
	Dec. 31, 2018
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Changes in AOCL by Component	The following tables represents the changes in Accumulated other comprehensive income (loss) by component: Quarter Ended December 31, 2018 Other comprehensive income (loss) Prior to reclassification Reclassification from Pre-tax Tax effect Net of tax Derivative instruments and hedges: Foreign exchange forward contracts 1 $ 1.2 $ (0.1 ) $ 1.1 $ (0.4 ) $ 0.7 Interest rate swaps 2 (5.1 ) (2.1 ) (7.2 ) 1.9 (5.3 ) Cross-currency swaps 2 2.2 — 2.2 (1.3 ) 0.9 Derivative instruments and hedges total (1.7 ) (2.2 ) (3.9 ) 0.2 (3.7 ) Foreign currency translation adjustment (13.6 ) — (13.6 ) — (13.6 ) Change in pension and postretirement defined benefit plans — 0.5 0.5 (0.1 ) 0.4 Total $ (15.3 ) $ (1.7 ) $ (17.0 ) $ 0.1 $ (16.9 ) December 31, 2018 Accumulated other comprehensive income (loss) Beginning Impacts of ASU 2018-02 Adoption Net activity Ending 3 Derivative instruments and hedges: Foreign exchange forward contracts 1 $ 0.2 $ — $ 0.7 $ 0.9 Interest rate swaps 2 18.3 0.8 (5.3 ) 13.8 Cross-currency swaps 2 (1.7 ) — 0.9 (0.8 ) Derivative instruments and hedges total 16.8 0.8 (3.7 ) 13.9 Foreign currency translation adjustment (105.3 ) — (13.6 ) (118.9 ) Change in pension and postretirement defined benefit plans (24.5 ) (6.2 ) 0.4 (30.3 ) Total $ (113.0 ) $ (5.4 ) $ (16.9 ) $ (135.3 ) 1 We are subject to variability in foreign currency exchange rates due to our international operations. Exposure to this variability is periodically managed primarily through the use of natural hedges, whereby funding obligations and assets are both managed in the local currency. From time-to-time, we enter into currency exchange agreements to manage our exposure arising from fluctuating exchange rates related to specific and projected transactions. We operate this program pursuant to documented corporate risk management policies and do not enter into derivative transactions for speculative purposes. The sensitivity of earnings and cash flows to variability in exchange rates is assessed by applying an appropriate range of potential rate fluctuations to our assets, obligations and projected results of operations denominated in foreign currencies. Our currency risk consists primarily of foreign currency denominated firm commitments and projected foreign currency denominated intercompany and third-party transactions. As of December 31, 2018 , the notional amount of open foreign exchange contracts was $69.9 million . These contracts were in a net asset position reported in Other current assets with a fair value of $1.7 million . The maximum length of time over which we hedge transaction exposures is generally 15 months. Derivative gains and losses, initially reported as a component of Accumulated other comprehensive income (loss), are reclassified to earnings in the period when the transaction affects earnings. 2 See Note 6 for information related to our interest rate and cross-currency swap agreements. 3 The estimated net amount of gains and losses that are reported in Accumulated other comprehensive income (loss) as of December 31, 2018 that is expected to be reclassified into earnings within the next 12 months is $5.2 million . Quarter Ended December 31, 2017 Other comprehensive income (loss) Accumulated other comprehensive income (loss) Prior to reclassification Reclassification from Pre-tax Tax effect Net of tax Beginning balance Net activity Ending balance Derivative instruments and hedges: Foreign exchange forward contracts $ (0.9 ) $ 0.4 $ (0.5 ) $ 0.1 $ (0.4 ) $ (0.4 ) $ (0.4 ) $ (0.8 ) Interest rate swaps 6.7 (0.8 ) 5.9 (2.1 ) 3.8 4.7 3.8 8.5 Derivative instruments and hedges total 5.8 (0.4 ) 5.4 (2.0 ) 3.4 4.3 3.4 7.7 Foreign currency translation adjustment 6.1 — 6.1 — 6.1 (81.3 ) 6.1 (75.2 ) Change in pension and postretirement defined benefit plans (0.1 ) 1.2 1.1 (0.3 ) 0.8 (33.0 ) 0.8 (32.2 ) Total $ 11.8 $ 0.8 $ 12.6 $ (2.3 ) $ 10.3 $ (110.0 ) $ 10.3 $ (99.7 )
Schedule of Items Reclassified out of AOCL	The following table represents the items reclassified out of Accumulated other comprehensive income (loss) and the related tax effects: Quarter Ended December 31 2018 2017 Amount Tax effect 4 Net of tax Amount reclassified Tax effect Net of tax Derivative instruments and hedges: Foreign exchange forward contracts 1 $ (0.1 ) $ 0.1 $ — $ 0.4 $ (0.1 ) $ 0.3 Interest rate swaps 2 (2.1 ) 0.6 (1.5 ) (0.8 ) 0.3 (0.5 ) Derivative instruments and hedges total (2.2 ) 0.7 (1.5 ) (0.4 ) 0.2 (0.2 ) Change in pension and postretirement defined benefit plans 3 0.5 (6.3 ) (5.8 ) 1.2 (0.3 ) 0.9 1 Reclassified from Accumulated other comprehensive income (loss) into Investment income and other, net . 2 Reclassified from Accumulated other comprehensive income (loss) into Interest expense . 3 Reclassified from Accumulated other comprehensive income (loss) into Cost of goods sold , Selling and administrative expenses and Investment income and other, net . These components are included in the computation of net periodic pension expense. 4 As a result of the adoption of ASU 2018-02, we reclassified $5.4 million from Accumulated other comprehensive income (loss) to Retained earnings.

Special Charges (Tables)

Special Charges (Tables)	3 Months Ended
	Dec. 31, 2018
Special Charges [Abstract]
Restructuring Activity	The reserve activity for severance and other benefits in the quarter ended December 31, 2018 was as follows: Balance as of September 30, 2018 $ 8.5 Expenses 3.2 Cash Payments (6.2 ) Reversals (0.5 ) Balance as of December 31, 2018 $ 5.0

Earnings per Common Share (Tabl

Earnings per Common Share (Tables)	3 Months Ended
	Dec. 31, 2018
Earnings Per Share [Abstract]
Calculated Earnings per Share	Earnings per share are calculated as follows (share information in thousands): Quarter Ended December 31 2018 2017 Net income $ 42.2 $ 88.3 Average basic shares outstanding 67,053 65,906 Add potential effect of exercise of stock options and other unvested equity awards 672 1,526 Average diluted shares outstanding 67,725 67,432 Net income per basic common share $ 0.63 $ 1.34 Net income per diluted common share $ 0.62 $ 1.31 Shares with anti-dilutive effect excluded from the computation of diluted EPS 486 233

Guarantees (Tables)

Guarantees (Tables)	3 Months Ended
	Dec. 31, 2018
Product Warranties Disclosures [Abstract]
Reconciliation of Changes in the Warranty Reserve	A rollforward of changes in the warranty reserve for the periods covered in this report is as follows: Quarter Ended December 31 2018 2017 Balance as of beginning of period $ 20.5 $ 25.5 Provision for warranties in the period 5.1 3.5 Warranty reserves assumed 1 2.8 — Warranty claims in the period (3.5 ) (3.7 ) Balance as of end of period $ 24.9 $ 25.3

Segment Reporting (Tables)

Segment Reporting (Tables)	3 Months Ended
	Dec. 31, 2018
Segment Reporting [Abstract]
Reconciliation of Segment Information to Consolidated Financial Information	Quarter Ended 2018 2017 Net revenue: Patient Support Systems $ 341.0 $ 334.4 Front Line Care 233.4 224.6 Surgical Solutions 109.1 110.7 Total net revenue $ 683.5 $ 669.7 Divisional income: Patient Support Systems $ 56.7 $ 53.4 Front Line Care 60.1 55.4 Surgical Solutions 11.2 9.7 Other operating costs: Non-allocated operating costs, administrative costs, and other 49.2 52.9 Special charges 8.0 13.5 Operating profit 70.8 52.1 Interest expense (21.3 ) (23.1 ) Investment income and other, net 0.1 1.8 Income before income taxes $ 49.6 $ 30.8

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Details) $ in Millions	3 Months Ended
	Dec. 31, 2018USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	$ (5.4)
Deferred Tax Assets, Valuation Allowance	$ 79.4
Revenue from Contract with Customer [Policy Text Block]	Revenue Recognition Revenue is recognized as performance obligations are satisfied, either at a point in time or over time, driven by the nature of the obligation that is contracted to be provided to our customers. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is the unit of account in the contract. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Certain of our contracts have multiple performance obligations. For contracts with multiple performance obligations, we allocate the contract’s transaction price to each performance obligation using our best estimate of the standalone selling price of each distinct good or service in the contract. The majority of our capital equipment revenue is recognized at a point in time, primarily based on the transfer of title, except in circumstances where we are also required to install the equipment, for which revenue is recognized upon customer acceptance of the installation. Performance obligations involving the provision of services and revenue from rental usage of our products are recognized over the time period specified in the contractual arrangement with the customer. Shipping and handling activities are considered to be fulfillment activities and are not considered to be a separate performance obligation. Revenue is presented net of several types of variable consideration including rebates, discounts and product returns, which are estimated at the time of sale generally using the expected value method, although the most likely amount method is also used for certain types of variable consideration. These estimates take into consideration historical experience, current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Certain costs associated with obtaining a contract, which primarily comprise sales commissions earned by Company personnel, are capitalized until such time as the related performance obligations are completed and the related revenue is recognized. Contract liabilities arise as a result of cash received from customers at inception of contracts or where the timing of billing for services precedes satisfaction of our performance obligations. Remaining performance obligations represent the portion of the contract price for which work has not been performed, primarily related to installation and service contracts. Taxes assessed by a governmental authority that are directly imposed on a revenue producing transaction between us and our customers, including but not limited to sales taxes, use taxes and value added taxes, are excluded from revenue and cost.
Accounting Standards Update 2016-16 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative Effect on Retained Earnings, before Tax	$ 5.8
Cumulative Effect on Retained Earnings, Tax	0.2
Cumulative Effect on Retained Earnings, Net of Tax	$ (5.6)

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Other Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Accounting Policies [Abstract]
Sale of businesses	$ 0	$ 1
Revenue from Contract with Customer [Policy Text Block]	Revenue Recognition Revenue is recognized as performance obligations are satisfied, either at a point in time or over time, driven by the nature of the obligation that is contracted to be provided to our customers. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is the unit of account in the contract. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Certain of our contracts have multiple performance obligations. For contracts with multiple performance obligations, we allocate the contract’s transaction price to each performance obligation using our best estimate of the standalone selling price of each distinct good or service in the contract. The majority of our capital equipment revenue is recognized at a point in time, primarily based on the transfer of title, except in circumstances where we are also required to install the equipment, for which revenue is recognized upon customer acceptance of the installation. Performance obligations involving the provision of services and revenue from rental usage of our products are recognized over the time period specified in the contractual arrangement with the customer. Shipping and handling activities are considered to be fulfillment activities and are not considered to be a separate performance obligation. Revenue is presented net of several types of variable consideration including rebates, discounts and product returns, which are estimated at the time of sale generally using the expected value method, although the most likely amount method is also used for certain types of variable consideration. These estimates take into consideration historical experience, current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Certain costs associated with obtaining a contract, which primarily comprise sales commissions earned by Company personnel, are capitalized until such time as the related performance obligations are completed and the related revenue is recognized. Contract liabilities arise as a result of cash received from customers at inception of contracts or where the timing of billing for services precedes satisfaction of our performance obligations. Remaining performance obligations represent the portion of the contract price for which work has not been performed, primarily related to installation and service contracts. Taxes assessed by a governmental authority that are directly imposed on a revenue producing transaction between us and our customers, including but not limited to sales taxes, use taxes and value added taxes, are excluded from revenue and cost.
Gain (Loss) on Disposition of Business		$ 1

Revenue Recognition (Details)

Revenue Recognition (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Oct. 01, 2018	Sep. 30, 2018	Sep. 30, 2017
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	$ 611.6	$ 575.2
Retained Earnings (Accumulated Deficit)	1,899.9
Accounts Receivable, Net, Current	537.9		$ 609.8	$ 580.7
Other Assets, Current	114.3		122	100.2
Property, Plant and Equipment, Net	316.2		322.7	328.3
Deferred Tax Assets, Net of Valuation Allowance, Noncurrent	34.9		40.6	35
Other Assets, Noncurrent	93.7		78.5	75.1
Deferred Revenue	84.4		87.5	40
Revenue Deferred due to ASC 606 Initial Adoption	58.4
Deferred Revenue, Additions	58.6
Deferred Revenue, Revenue Recognized	(55.9)
Other Liabilities, Current	71.6		67.9	67.1
Other Liabilities, Noncurrent	75.1		51.3	40.4
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	1,551.5	1,464.1		1,616.2	$ 1,365.6
Product sales and service revenue	683.5	669.7
Rental revenue	71.9	94.5
Cost of Goods and Services Sold	316.3	304.1
Rental expenses	37.2	46
Income tax expense (benefit)	7.4	(57.5)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	42.2	88.3
Capitalized Contract Cost, Impairment Loss	7.9
Capitalized Contract Cost, Amortization	3.4
Accounting Standards Update 2014-09 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Cumulative Effect on Retained Earnings, Net of Tax	(4.9)
Cumulative Effect on Retained Earnings, Tax	4.8
Retained Earnings [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	1,899.9	1,752.5	$ 1,871.3	1,876.2	$ 1,676.2
Retained Earnings [Member] | Accounting Standards Update 2014-09 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Cumulative Effect on Retained Earnings, Net of Tax	(4.9)
Other Current Assets [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Equipment and Other Costs	20.7
Other Assets [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Equipment and Other Costs	3.5
Other Current Liabilities [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Deferred Revenue	108.9			$ 47.8
Calculated under Revenue Guidance in Effect before Topic 606 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	587.6
Retained Earnings (Accumulated Deficit)	1,904.8
Accounts Receivable, Net, Current	508.3
Other Assets, Current	91.8
Property, Plant and Equipment, Net	322.3
Deferred Tax Assets, Net of Valuation Allowance, Noncurrent	29.3
Other Assets, Noncurrent	90.2
Deferred Revenue	35.7
Other Liabilities, Current	70.9
Other Liabilities, Noncurrent	64
Product sales and service revenue	684.2
Rental revenue	96.6
Cost of Goods and Services Sold	310.9
Rental expenses	42.8
Income tax expense (benefit)	7.5
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	42.6
UNITED STATES
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	468.5
UNITED STATES | Calculated under Revenue Guidance in Effect before Topic 606 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	469.4
Non-US [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	215
Non-US [Member] | Calculated under Revenue Guidance in Effect before Topic 606 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	214.8
Patient Support Systems [Member] | Calculated under Revenue Guidance in Effect before Topic 606 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	342.2
Patient Support Systems [Member] | UNITED STATES | Calculated under Revenue Guidance in Effect before Topic 606 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	249.5
Patient Support Systems [Member] | Non-US [Member] | Calculated under Revenue Guidance in Effect before Topic 606 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	92.7
Front Line Care [Member] | Calculated under Revenue Guidance in Effect before Topic 606 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	232.9
Front Line Care [Member] | UNITED STATES | Calculated under Revenue Guidance in Effect before Topic 606 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	166
Front Line Care [Member] | Non-US [Member] | Calculated under Revenue Guidance in Effect before Topic 606 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	66.9
Surgical Solutions [Member] | Calculated under Revenue Guidance in Effect before Topic 606 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	109.1
Surgical Solutions [Member] | UNITED STATES | Calculated under Revenue Guidance in Effect before Topic 606 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	53.9
Surgical Solutions [Member] | Non-US [Member] | Calculated under Revenue Guidance in Effect before Topic 606 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	55.2
Operating Segments [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	683.5	669.7
Operating Segments [Member] | Patient Support Systems [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	341	334.4
Operating Segments [Member] | Patient Support Systems [Member] | UNITED STATES
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	248.1
Operating Segments [Member] | Patient Support Systems [Member] | Non-US [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	92.9
Operating Segments [Member] | Front Line Care [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	233.4	224.6
Operating Segments [Member] | Front Line Care [Member] | UNITED STATES
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	166.5
Operating Segments [Member] | Front Line Care [Member] | Non-US [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	66.9
Operating Segments [Member] | Surgical Solutions [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	109.1	$ 110.7
Operating Segments [Member] | Surgical Solutions [Member] | UNITED STATES
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	53.9
Operating Segments [Member] | Surgical Solutions [Member] | Non-US [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Product sales and service revenue	$ 55.2

Supplementary Balance Sheet I_3

Supplementary Balance Sheet Information (Details) - USD ($) $ in Millions	Dec. 31, 2018	Sep. 30, 2018
Equity Securities without Readily Determinable Fair Value, Amount	$ 26.6
Allowance for possible losses and discounts on trade receivables	22.4	$ 21.8
Inventories, net of reserves:
Finished products	140.7	139.7
Raw materials and work in process	159.2	152
Total inventories, net of reserves	299.9	291.7
Accumulated depreciation of property, plant and equipment	569.2	586.7
Accumulated amortization of software and other intangible assets	$ 558.6	$ 532.8
Preferred stock, without par value:
Shares authorized	1,000,000	1,000,000
Shares issued	0	0
Common stock, without par value:
Shares authorized	199,000,000	199,000,000
Shares issued (in shares)	88,457,634	88,457,634
Shares outstanding (in shares)	66,657,887	67,256,112
Treasury shares (in shares)	21,799,747	21,201,522
Other Assets [Member]
Investments	$ 50.9	$ 24.6

Business Combinations Acquisiti

Business Combinations Acquisition (Mortara Instruments) (Details) - USD ($)	3 Months Ended
	Dec. 31, 2018	Feb. 28, 2017
Business Acquisition [Line Items]
Royalty Guarantees, Commitments, Amount	$ 22,000,000
Goodwill	$ 1,731,900,000
Trade names (7-year weighted average useful life) | Mortara [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	7 years
Customer relationships (8-year useful life) | Mortara [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	8 years
Developed technology (7-year useful life) | Mortara [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	7 years
Senior Unsecured 5.00% Notes due on February 14, 2025 [Member]
Business Acquisition [Line Items]
Aggregate value of debt		$ 300,000,000

Business Combinations Kaz (Deta

Business Combinations Kaz (Details) - USD ($) $ in Millions	Oct. 01, 2018	Dec. 31, 2017	Dec. 31, 2018
Business Combinations [Abstract]
Cash Paid for Asset Acquisition	$ 17.1
Royalty Guarantees, Commitments, Amount			$ 22
Gain (Loss) on Disposition of Business		$ 1

Goodwill (Schedule of Goodwill

Goodwill (Schedule of Goodwill Activity) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2018	Sep. 30, 2018
Goodwill [Roll Forward]
Goodwill	$ 2,204.7	$ 2,211.1
Accumulated impairment losses	(472.8)	(472.8)
Goodwill, net	1,731.9	1,738.3
Currency translation effect	(6.4)
Patient Support Systems [Member]
Goodwill [Roll Forward]
Goodwill	544	544.4
Accumulated impairment losses	(472.8)	(472.8)
Goodwill, net	71.2	71.6
Currency translation effect	(0.4)
Front Line Care [Member]
Goodwill [Roll Forward]
Goodwill	1,366.5	1,370.6
Accumulated impairment losses	0	0
Goodwill, net	1,366.5	1,370.6
Currency translation effect	(4.1)
Surgical Solutions [Member]
Goodwill [Roll Forward]
Goodwill	294.2	296.1
Accumulated impairment losses	0	0
Goodwill, net	294.2	$ 296.1
Currency translation effect	$ (1.9)

Financing Agreements (Schedule

Financing Agreements (Schedule of Total Debt) (Details)	3 Months Ended
	Dec. 31, 2018USD ($)derivative	Dec. 31, 2017USD ($)	Sep. 30, 2018USD ($)	May 31, 2018USD ($)	Feb. 28, 2017USD ($)
Debt Instrument [Line Items]
Repayments of Long-term Debt	$ 0	$ 27,400,000
Long-term Debt, by Current and Noncurrent [Abstract]
Current portion of long-term debt	100,000		$ 100,000
Total debt	2,004,900,000		1,972,900,000
Less Short-term borrowings	188,400,000		182,500,000
Total Long-term debt	1,816,500,000		1,790,400,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Letters of Credit Outstanding, Amount	8,000,000
Long-term Debt, by Current and Noncurrent [Abstract]
Revolving credit facility, matures September 2021	25,000,000		0
Line of Credit Facility, Maximum Borrowing Capacity	$ 700,000,000
Debt instrument, maturity date	Sep. 1, 2021
Line of Credit Facility, Remaining Borrowing Capacity	$ 667,000,000
Senior Secured Credit Facilities [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Interest Rate During Period	4.10%
Senior Secured Term Loan A [Member]
Debt Instrument [Line Items]
Long-term Debt, Maturities, Repayments of Principal in Year Three	$ 0
Line of Credit Facility, Interest Rate During Period	0.00%
Long-term Debt, by Current and Noncurrent [Abstract]
Line of Credit Facility, Maximum Borrowing Capacity	$ 1,462,500,000
Debt instrument, maturity date	Sep. 30, 2021
Total Long-term debt	$ 1,030,500,000		1,029,700,000
Long-term Debt, Maturities, Repayments of Principal in Year Five	$ 0
Senior Unsecured 5.75% Notes due on September 1, 2023 [Member]
Long-term Debt, by Current and Noncurrent [Abstract]
Unsecured debenture interest rate	5.75%
Debt Instrument, Face Amount	$ 425,000,000
Debt instrument, maturity date	Sep. 1, 2023
Total Long-term debt	$ 421,000,000		420,800,000
Senior Unsecured 5.00% Notes due on February 14, 2025 [Member]
Long-term Debt, by Current and Noncurrent [Abstract]
Unsecured debenture interest rate	5.00%
Debt Instrument, Face Amount					$ 300,000,000
Debt instrument, maturity date	Feb. 15, 2025
Total Long-term debt	$ 296,500,000		296,400,000
Unsecured 7.00% Debentures Due on February 15, 2024 [Member]
Long-term Debt, by Current and Noncurrent [Abstract]
Unsecured debenture interest rate	7.00%
Debt instrument, maturity date	Feb. 15, 2024
Total debt	$ 13,500,000		13,600,000
Unsecured 6.75% Debentures Due on December 15, 2027 [Member]
Long-term Debt, by Current and Noncurrent [Abstract]
Unsecured debenture interest rate	6.75%
Debt instrument, maturity date	Dec. 15, 2027
Total debt	$ 29,600,000		29,500,000
Securitization Program [Member]
Long-term Debt, by Current and Noncurrent [Abstract]
Unsecured debenture interest rate	0.675%
Debt Instrument, Face Amount				$ 110,000,000
Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement	$ 110,000,000		110,000,000
Note Securitization Facility [Member]
Long-term Debt, by Current and Noncurrent [Abstract]
Debt Instrument, Face Amount				$ 90,000,000
Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement	78,300,000		72,400,000
Other Financing Agreements [Member]
Long-term Debt, by Current and Noncurrent [Abstract]
Total debt	$ 400,000		$ 400,000
Interest Rate Swap [Member]
Debt Instrument [Line Items]
Derivative, Number of Instruments Held | derivative	5

Financing Agreements (Future Pr

Financing Agreements (Future Principal Payments of Long-Term Debt) (Details)	Dec. 31, 2018USD ($)
Interest Rate Swap [Member]
Debt Instrument [Line Items]
Derivative, Notional Amount	$ 750,000,000

Financing Agreements (Narrative

Financing Agreements (Narrative) (Details)	1 Months Ended	3 Months Ended
	May 31, 2018USD ($)	Dec. 31, 2018USD ($)derivative	Dec. 31, 2017USD ($)	Sep. 30, 2018USD ($)	Feb. 28, 2017USD ($)
Debt Instrument [Line Items]
Payment of long-term debt		$ 0	$ 27,400,000
Interest Rate Swap [Member]
Debt Instrument [Line Items]
Number of derivative agreements | derivative		5
Interest rate swap agreement, notional amount		$ 750,000,000
Currency Swap [Member]
Debt Instrument [Line Items]
Number of derivative agreements | derivative		2
Interest rate swap agreement, notional amount		$ 198,700,000
Interest rate swap, fair value		5,600,000
Securitization Program [Member]
Debt Instrument [Line Items]
Debt Instrument, Term	364 days
Aggregate value of debt	$ 110,000,000
Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement		$ 110,000,000		$ 110,000,000
Unsecured debenture interest rate		0.675%
Note Securitization Facility [Member]
Debt Instrument [Line Items]
Aggregate value of debt	$ 90,000,000
Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement		$ 78,300,000		72,400,000
Senior Secured Term Loan A [Member]
Debt Instrument [Line Items]
Long-term Debt, Maturities, Repayments of Principal in Year Three		0
Senior revolving credit facility, maximum borrowing amount		$ 1,462,500,000
Debt instrument, maturity date		Sep. 30, 2021
Maximum interest rate during period		0.00%
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Senior revolving credit facility, maximum borrowing amount		$ 700,000,000
Debt instrument, maturity date		Sep. 1, 2021
Revolving credit facility, matures September 2021		$ 25,000,000		0
Current borrowing capacity under the facility		667,000,000
Outstanding letters of credit		$ 8,000,000
Senior Secured Credit Facilities [Member]
Debt Instrument [Line Items]
Maximum interest rate during period		4.10%
Senior Unsecured 5.75% Notes due on September 1, 2023 [Member]
Debt Instrument [Line Items]
Debt instrument, maturity date		Sep. 1, 2023
Aggregate value of debt		$ 425,000,000
Unsecured debenture interest rate		5.75%
Senior Unsecured 5.00% Notes due on February 14, 2025 [Member]
Debt Instrument [Line Items]
Debt instrument, maturity date		Feb. 15, 2025
Aggregate value of debt					$ 300,000,000
Unsecured debenture interest rate		5.00%
London Interbank Offered Rate (LIBOR) [Member] | Securitization Program [Member]
Debt Instrument [Line Items]
Unsecured debenture interest rate		0.80%
London Interbank Offered Rate (LIBOR) [Member] | Note Securitization Facility [Member]
Debt Instrument [Line Items]
Unsecured debenture interest rate		1.00%
Other Assets [Member] | Interest Rate Swap [Member]
Debt Instrument [Line Items]
Interest rate swap, fair value		$ 13,000,000		$ 24,800,000
Other Current Liabilities [Member] | Currency Swap [Member]
Debt Instrument [Line Items]
Derivative, Fair Value, Net		$ 1,200,000

Financing Agreements (Schedul_2

Financing Agreements (Schedule of Covenants) (Details) - Scenario, Forecast [Member]	Dec. 31, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Secured Net Leverage Ratio	3	3.50
Interest Coverage Ratio	4	3.75

Financing Agreements (Schedul_3

Financing Agreements (Schedule of Fair Value) (Details) - USD ($) $ in Millions	Dec. 31, 2018	Sep. 30, 2018
Debt Instrument [Line Items]
Total	$ 1,751.2	$ 1,766.1
Unsecured Debentures [Member]
Debt Instrument [Line Items]
Fair value of unsecured notes	41.1	42.9
Senior Secured Term Loan A [Member]
Debt Instrument [Line Items]
Senior secured Term Loan A	995.8	991.9
Senior Unsecured 5.75% Notes due on September 1, 2023 [Member]
Debt Instrument [Line Items]
Fair value of unsecured notes	426.9	437.3
Senior Unsecured 5.00% Notes due on February 14, 2025 [Member]
Debt Instrument [Line Items]
Fair value of unsecured notes	$ 287.4	$ 294

Retirement and Postretirement_3

Retirement and Postretirement Plans (Defined Benefit Plans) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Defined Benefit Plan Disclosure [Line Items]
Interest cost	$ 3.1	$ 2.7
Expected return on plan assets	(3.7)	(3.9)
Amortization of net loss	0.6	1.2
Net pension expense	1.1	1.2
Cost of Goods, Total [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	0.3	0.3
Selling, General and Administrative Expenses [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 0.8	$ 0.9

Retirement and Postretirement_4

Retirement and Postretirement Plans (Defined Contribution Plans) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Retirement Benefits [Abstract]
Defined contribution savings plans expense	$ 6.2	$ 6.4

Other Comprehensive Income (L_3

Other Comprehensive Income (Loss) (Schedule of Changes in AOCL by Component) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Accumulated Other Comprehensive Income (Loss) [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	$ 5.2
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	(5.4)
Other comprehensive income (loss)
Total Other Comprehensive Income (Loss), net of tax	(16.9)	$ 10.3
Accumulated other comprehensive loss
Beginning balance	1,616.2
Net activity	(16.9)	10.3
Ending balance	1,551.5
Available-for-sale Securities and Hedges [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	0.8
Other comprehensive income (loss)
Prior to reclassification	(1.7)	5.8
Reclassification from	(2.2)	(0.4)
Pre-tax	(3.9)	5.4
Tax effect	0.2	(2)
Total Other Comprehensive Income (Loss), net of tax	(3.7)	3.4
Accumulated other comprehensive loss
Beginning balance	16.8	4.3
Net activity	(3.7)	3.4
Ending balance	13.9	7.7
Foreign Currency Translation Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	0
Other comprehensive income (loss)
Prior to reclassification	(13.6)	6.1
Reclassification from	0	0
Pre-tax	(13.6)	6.1
Tax effect	0	0
Total Other Comprehensive Income (Loss), net of tax	(13.6)	6.1
Accumulated other comprehensive loss
Beginning balance	(105.3)	(81.3)
Net activity	(13.6)	6.1
Ending balance	(118.9)	(75.2)
Change in Pension and Postretirement Defined Benefit Plans [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	(6.2)
Other comprehensive income (loss)
Prior to reclassification	0	(0.1)
Reclassification from	0.5	1.2
Pre-tax	0.5	1.1
Tax effect	(0.1)	(0.3)
Total Other Comprehensive Income (Loss), net of tax	0.4	0.8
Accumulated other comprehensive loss
Beginning balance	(24.5)	(33)
Net activity	0.4	0.8
Ending balance	(30.3)	(32.2)
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	(5.4)
Other comprehensive income (loss)
Prior to reclassification	(15.3)	11.8
Reclassification from	(1.7)	0.8
Pre-tax	(17)	12.6
Tax effect	0.1	(2.3)
Total Other Comprehensive Income (Loss), net of tax	(16.9)	10.3
Accumulated other comprehensive loss
Beginning balance	(113)	(110)
Net activity	(16.9)	10.3
Ending balance	(135.3)	(99.7)
Foreign Exchange Forward [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	0
Foreign Exchange Forward [Member] | Available-for-sale Securities and Hedges [Member]
Other comprehensive income (loss)
Prior to reclassification	1.2	(0.9)
Reclassification from	0.1	(0.4)
Pre-tax	1.1	(0.5)
Tax effect	0.4	(0.1)
Total Other Comprehensive Income (Loss), net of tax	0.7	(0.4)
Accumulated other comprehensive loss
Beginning balance	0.2	(0.4)
Net activity	0.7	(0.4)
Ending balance	0.9	(0.8)
Interest Rate Swap [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	0.8
Interest Rate Swap [Member] | Available-for-sale Securities and Hedges [Member]
Other comprehensive income (loss)
Prior to reclassification	(5.1)	6.7
Reclassification from	2.1	0.8
Pre-tax	(7.2)	5.9
Tax effect	(1.9)	2.1
Total Other Comprehensive Income (Loss), net of tax	(5.3)	3.8
Accumulated other comprehensive loss
Beginning balance	18.3	4.7
Net activity	(5.3)	3.8
Ending balance	13.8	$ 8.5
Currency Swap [Member] | Available-for-sale Securities and Hedges [Member]
Other comprehensive income (loss)
Prior to reclassification	2.2
Reclassification from	0
Foreign Exchange Contract [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	0
Foreign Exchange Contract [Member] | Available-for-sale Securities and Hedges [Member]
Other comprehensive income (loss)
Pre-tax	2.2
Tax effect	1.3
Total Other Comprehensive Income (Loss), net of tax	0.9
Accumulated other comprehensive loss
Beginning balance	(1.7)
Net activity	0.9
Ending balance	$ (0.8)

Other Comprehensive Income (L_4

Other Comprehensive Income (Loss) (Schedule of Items Reclassified out of AOCL) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amount reclassified	$ (49.6)	$ (30.8)
Tax effect	7.4	(57.5)
Net of tax	(42.2)	(88.3)
Available-for-sale Securities and Hedges [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	2.2	0.4
Net of tax	(1.5)	(0.2)
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	0	0
Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	(0.5)	(1.2)
Reclassification out of Accumulated Other Comprehensive Income [Member] | Available-for-sale Securities and Hedges [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Tax effect	0.7	0.2
Reclassification out of Accumulated Other Comprehensive Income [Member] | Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amount reclassified	0.5	1.2
Tax effect	(6.3)	(0.3)
Net of tax	(5.8)	0.9
Foreign Exchange Forward [Member] | Available-for-sale Securities and Hedges [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	(0.1)	0.4
Tax effect	0.1	(0.1)
Net of tax	0	(0.3)
Interest Rate Swap [Member] | Available-for-sale Securities and Hedges [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	(2.1)	(0.8)
Tax effect	0.6	0.3
Net of tax	$ 1.5	$ 0.5

Special Charges (Narrative) (De

Special Charges (Narrative) (Details) $ in Millions	3 Months Ended
	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Jun. 30, 2015site
Restructuring Cost and Reserve [Line Items]
Special charges	$ 8	$ 13.5
Gain (Loss) on Disposition of Business		1
Restructuring charges	3.2
Number of site closures | site			8
Integration and Business Realignment [Member]
Restructuring Cost and Reserve [Line Items]
Special charges	0.1	0.3
Site Consolidation [Member] | Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Special charges		0.2
Site Consolidation [Member] | Facility Closing [Member]
Restructuring Cost and Reserve [Line Items]
Special charges	4.1	4.1
Aggregate special charges recognized	54.9
Business Optimization [Member]
Restructuring Cost and Reserve [Line Items]
Special charges	3.8	9.1
Business Optimization [Member] | Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Special charges	$ 2.7	$ 6

Special Charges (Schedule of Re

Special Charges (Schedule of Restructuring Activity) (Details) $ in Millions	3 Months Ended
	Dec. 31, 2018USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Accrual Adjustment	$ (0.5)
Restructuring Reserve [Roll Forward]
Beginning Balance	8.5
Expenses	3.2
Cash Payments	(6.2)
Ending Balance	$ 5

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Sep. 30, 2019	Sep. 30, 2018	Jan. 01, 2018
Effective tax rate	14.90%	(186.70%)
Proceeds and Excess Tax Benefit from Share-based Compensation	$ 3.1
Federal Corporate tax rate	21.00%	35.00%			21.00%
Deferred Tax Remeasurement, Amount				$ (93.8)
Blended Corporate Tax rate	24.50%
Federal statutory income tax rate			21.00%
Global intangible low-taxed income- foreign tax deduction	50.00%
Discrete net tax benefit- Tax Act	$ 64.3	$ 2.9		70.9
Income Tax Expense (Benefit)	7.4	$ (57.5)
Transition tax obligation, amount	21.9			$ 22.9
Reduction to Transition Tax Liability	1
Reduction in Taxes [Member]
Transition tax obligation, amount	$ 1

Earnings per Common Share (Deta

Earnings per Common Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Dec. 31, 2017
Earnings Per Share [Abstract]
Net Income (Loss) Attributable to Parent	$ 42.2		$ 88.3
Average Common Shares Outstanding - Basic (in shares)	67,053		65,906
Add potential effect of exercise of stock options and other unvested equity awards (in shares)	672		1,526
Average shares outstanding - Diluted (in shares)	67,725		67,432
Net income attributable to common shareholders per common share - Basic (usd per share)		$ 0.63	$ 1.34
Net income attributable to common shareholders per common share - Diluted (usd per share)		$ 0.62	$ 1.31
Shares with anti-dilutive effect excluded from the computation of Diluted EPS (in shares)	486		233

Common Stock (Details)

Common Stock (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Class of Stock Disclosures [Abstract]
Stock based compensation cost charged against income, net of tax	$ 4.2	$ 4.6

Common Stock Common Stock (Shar

Common Stock Common Stock (Share Repurchase Program) (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Equity, Class of Treasury Stock [Line Items]
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 89.7
Shares acquired through share repurchase program	0.8
Payments for Repurchase of Common Stock		$ 0
Payments for Repurchase of Common Stock	$ (75)

Common Stock Common Stock (Narr

Common Stock Common Stock (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		64 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Payments Related to Tax Withholding for Share-based Compensation	$ 3.5	$ 3.5
Payments for Repurchase of Common Stock		$ 0
Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares Paid for Tax Withholding for Share Based Compensation	(37,445)	(43,374)
Stock Repurchased During Period, Value			$ 250.3

Guarantees (Details)

Guarantees (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Movement in Standard Product Warranty Accrual [Roll Forward]
Balance at beginning of period	$ 20.5	$ 25.5
Provision for warranties in the period	5.1	3.5
Standard Product Warranty Accrual, Additions from Business Acquisition	2.8	0
Warranty claims in the period	(3.5)	(3.7)
Balance at end of period	$ 24.9	$ 25.3

Segment Reporting (Details)

Segment Reporting (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Segment Reporting Information [Line Items]
Revenues	$ 683.5	$ 669.7
Operating profit	70.8	52.1
Special charges	8	13.5
Interest expense	(21.3)	(23.1)
Investment income and other, net	0.1	1.8
Income Before Income Taxes	49.6	30.8
Corporate and Other [Member]
Segment Reporting Information [Line Items]
Non-Allocated operating costs, administrative and other	49.2	52.9
Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues	683.5	669.7
Operating Segments [Member] | Patient Support Systems [Member]
Segment Reporting Information [Line Items]
Revenues	341	334.4
Operating profit	56.7	53.4
Operating Segments [Member] | Front Line Care [Member]
Segment Reporting Information [Line Items]
Revenues	233.4	224.6
Operating profit	60.1	55.4
Operating Segments [Member] | Surgical Solutions [Member]
Segment Reporting Information [Line Items]
Revenues	109.1	110.7
Operating profit	$ 11.2	$ 9.7

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2017	Dec. 31, 2018
Loss Contingencies [Line Items]
Gain (Loss) on Disposition of Business	$ 1
Uninsured Risk [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Deductibles and self-insured retentions		$ 1